Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'Pico-Bello-Klean study': effectiveness and patient tolerability of bowel preparation agents sodium picosulphate-magnesium citrate and polyethylene glycol before colonoscopy. A single-blinded randomized trial.1 passage
• A 'cocoon immunization strategy' among patients with inflammatory bowel disease.1 passage
• A 'real-world' analysis of risk factors for post liver transplant delirium and the effect on length of stay.1 passage
• A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients.1 passage
• A 13-year time trend analysis of 3724 small bowel video capsule endoscopies and a forecast model during the financial crisis in Greece.1 passage
• A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients.1 passage
• A clinical prediction model to assess risk for pancreatic cancer among patients with prediabetes.1 passage
• A clinician's guide to the cost and health benefits of hepatitis C cure assessed from the individual patient perspective.1 passage
• A comparison of sedation with midazolam-ketamine versus propofol-fentanyl during endoscopy in children: a randomized trial.1 passage
• A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.1 passage
• A multicenter randomized comparison between high-definition white light endoscopy and narrow band imaging for detection of gastric lesions.1 passage
• A new model combining the liver/spleen volume ratio and classification of varices predicts HVPG in hepatitis B patients with cirrhosis.1 passage
• A new panenteric capsule endoscopy-based strategy in patients with melena and a negative upper gastrointestinal endoscopy: a prospective feasibility study.1 passage
• A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients.1 passage
• A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.1 passage
• A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B.1 passage
• A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.1 passage
• A novel method: can stapedial acoustic reflex have a role in the diagnosis of minimal hepatic encephalopathy?1 passage
• A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study.1 passage
• A novel scoring model for predicting mortality risk in patients with cirrhosis and hepatorenal syndrome.1 passage
• A novel value-based scoring system for endoscopic ultrasound-guided drainage of pancreatic fluid collections: a single-centre comparative study of plastic and lumen-apposing metal stents (NOVA study).1 passage
• A patient with Crohn's disease during remission by biological agent treatment developed active pulmonary tuberculosis and determining the eating habits.1 passage
• A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis.1 passage
• A population-based US study of hepatitis C diagnosis rate.1 passage
• A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.1 passage
• A prognostic index for patients within the intermediate stage of hepatocellular carcinoma.1 passage
• A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.1 passage
• A proposal for a useful algorithm to diagnose small hepatocellular carcinoma on MRI.1 passage
• A prospective cohort study of the use of the fatty liver index and Fibroscan to determine the prevalence of fatty liver disease in an Irish population.1 passage
• A prospective study comparing patient-reported outcomes in Crohn's disease.1 passage
• A randomized controlled trial comparing continuous and as-required nitrous oxide use during screening colonoscopy.1 passage
• A randomized controlled trial of the effects of local tranexamic acid on mortality, rebleeding, and recurrent endoscopy need in patients with upper gastrointestinal hemorrhage.1 passage
• A randomized double-blinded sham-controlled cross-over trial of tined-lead sacral nerve stimulation testing for chronic constipation.1 passage
• A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms.1 passage
• A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.1 passage
• A randomized-controlled trial of early endotherapy versus wait-and-see policy for mild symptomatic pancreatic stones in chronic pancreatitis.1 passage
• A rare presentation of hypovolemic shock secondary to Whipple's disease.1 passage
• A retrospective study assessing fully covered metal stents as first-line management for malignant biliary strictures.1 passage
• A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection.1 passage
• A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis.1 passage
• A review article on gastric varices with focus on the emerging role of endoscopic ultrasound-guided angiotherapy.1 passage
• A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease.1 passage
• A state-of-the-art comprehensive review summarizing the emerging data on endoscopic ultrasound-guided liver diseases management.1 passage
• A systematic review and meta-analysis of disease severity and risk of recurrence in young versus elderly patients with left-sided acute diverticulitis.1 passage
• A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment.1 passage
• A systematic review and meta-analysis on outcomes after Rx or R1 endoscopic resection of superficial gastric cancer.1 passage
• A systematic review of biodegradable biliary stents: promising biocompatibility without stent removal.1 passage
• A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes.1 passage
• A systematic review on the complications and management of hepatic adenomas: a call for a new approach.1 passage
• A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.1 passage
• AIMS65 predicts prognosis of patients with duodenal ulcer bleeding; a comparison with other risk-scoring systems.1 passage
• AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.1 passage
• Abnormal serum iron markers in chronic hepatitis B virus infection may be because of liver injury.1 passage
• Acceptability and efficacy of a gel hypotonic oral rehydration solution in children with acute gastroenteritis.1 passage
• Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals.1 passage
• Accuracy of liver and spleen stiffness on magnetic resonance elastography for detecting portal hypertension: a systematic review and meta-analysis.1 passage
• Accuracy of liver stiffness-based model by different imaging modalities in compensated advanced chronic liver disease.1 passage
• Accurate measurement of colorectal polyps using computer-aided analysis.1 passage
• Acetarsol in the management of mesalazine-refractory ulcerative proctitis: a tertiary-level care experience.1 passage
• Acid-base disturbance in patients with cirrhosis: relation to hemodynamic dysfunction.1 passage
• Acoustic radiation force impulse elastography: comparison and combination with other noninvasive tests for the diagnosis of compensated liver cirrhosis.1 passage
• Acoustic radiation force impulse imaging of pancreas in patients with early onset idiopathic recurrent acute pancreatitis.1 passage
• Acoustic radiation forced impulse-based splenic prediction model using data mining for the noninvasive prediction of esophageal varices in hepatitis C virus advanced fibrosis.1 passage
• Activities in a social networking-based discussion group by endoscopic retrograde cholangiopancreatography doctors.1 passage
• Acute circulatory failure-chronic liver failure-sequential organ failure assessment score: a novel scoring model for mortality risk prediction in critically ill cirrhotic patients with acute circulatory failure.1 passage
• Acute gastrointestinal bleeding - a new approach to clinical and endoscopic management.1 passage
• Acute gastrointestinal bleeding cases presenting to the emergency department are associated with age, sex and seasonal and circadian factors.1 passage
• Acute pancreatitis in end-stage renal disease patients in the USA: a nationwide, propensity score-matched analysis.1 passage
• Acute pancreatitis in oldest old: a 10-year retrospective analysis of patients referred to the emergency department of a large tertiary hospital.1 passage
• Acute pancreatitis in the elderly: a cause for increased concern?1 passage
• Acute-on-chronic liver failure in Egypt: an underestimated complication of liver cirrhosis.1 passage
• Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis.1 passage
• Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.1 passage
• Adaptation of liver stiffness measurement depth in bariatric surgery candidates with suspected nonalcoholic fatty liver disease.1 passage
• Add-on sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness: a real-world experience.1 passage
• Adding a liquid test meal to a standardized lactulose hydrogen breath test significantly influences abdominal symptom generation and hydrogen values.1 passage
• Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy.1 passage
• Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions.1 passage
• Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina.1 passage
• Adherence to diagnostic guidelines of hepatocellular carcinoma: 12-year experience in a veterans affairs medical center.1 passage
• Adherence to follow-up and treatment recommendations in Greek and immigrant patients with chronic hepatitis B in Greece.1 passage
• Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?1 passage
• Adjusting the starting dose of telaprevir according to renal function decreases adverse effects and affects the sustained virological response rate.1 passage
• Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills.1 passage
• Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.1 passage
• African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians.1 passage
• Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase.1 passage
• Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.1 passage
• Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.1 passage
• Albumin-bilirubin score is associated with in-hospital mortality in critically ill patients with acute pancreatitis.1 passage
• Alcohol consumption and risk of gallstone disease: a meta-analysis.1 passage
• Alcohol consumption increases the incidence of hepatocellular carcinoma in patients with hepatitis B cirrhosis but not in patients with hepatitis C cirrhosis.1 passage
• Alcohol, smoking and rectal cancer risk in a Mediterranean cohort of adults: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Italy cohort.1 passage
• Alpha-1 antitrypsin deficiency is under-recognized in individuals with cirrhosis undergoing liver transplantation.1 passage
• Altered brain morphology in chronic pancreatitis patients and its association with pain and other disease characteristics.1 passage
• Alternative bibliometrics from impact factor improved the esteem of a journal in a 2-year-ahead annual-citation calculation: multivariate analysis of gastroenterology and hepatology journals.1 passage
• Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases.1 passage
• Ambulatory seton placement followed by fistulotomy: efficacy and safety for perianal fistula treatment.1 passage
• Aminotransferase-to-platelet ratio index and Fibrosis-4 index score predict hepatic fibrosis evaluated by transient hepatic elastography in hepatitis C virus-infected hemodialysis patients.1 passage
• Among inpatients, ischemic bowel disease predisposes to Clostridium difficile infection with concomitant higher mortality and worse outcomes.1 passage
• Amyloidosis of the gastrointestinal tract and the liver: clinical context, diagnosis and management.1 passage
• An effectiveness study of group psychoeducation for hepatitis C patients in community clinics.1 passage
• An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy.1 passage
• An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment.1 passage
• Analysis of risk factors for gallbladder polyp formation - A retrospective study based on serial ultrasounds.1 passage
• Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization.1 passage
• Analysis of the hemostatic therapy in liver transplantation guided by rotational thromboelastometry or conventional laboratory tests.1 passage
• Analysis of the prognostic factors for low rectal cancer with the pT1-2NxM0 stage after abdominoperineal resection.1 passage
• Anaphylaxis after wheat ingestion in a patient with coeliac disease: two kinds of reactions and the same culprit food.1 passage
• Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis.1 passage
• Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.1 passage
• Anorectal complications in patients with haematological malignancies.1 passage
• Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease.1 passage
• Antibacterial gauzes are effective in preventing infections after percutaneous endoscopic gastrostomy placement: a retrospective analysis.1 passage
• Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease.1 passage
• Antipsychotic medication and oropharyngeal dysphagia: systematic review.1 passage
• Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis.1 passage
• Anxiety and depression in patients with Barrett's esophagus: estimates of disorder rates and associations with symptom load and treatment-seeking.1 passage
• Applicability of endoscopic indices in the determination of disease activity in patients with ulcerative colitis.1 passage
• Application of Hemocoagulase Bothrops Atrox in the submucosal injection for endoscopic submucosal dissection: a preliminary trial.1 passage
• Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.1 passage
• Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.1 passage
• Approval of pembrolizumab for first-line treatment of microsatellite instability-high/mismatch repair deficient colorectal cancer: estimation of incremental benefit based on restricted mean survival time.1 passage
• Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.1 passage
• Are floating stools associated with specific functional bowel disorders?1 passage
• Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.1 passage
• Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.1 passage
• Arterial and liver stiffness in patients with non-alcoholic fatty liver disease: hitting two targets with sodium-glucose co-transporter-2 inhibitors.1 passage
• Arterial stiffness is associated independently with liver stiffness in biopsy-proven nonalcoholic fatty liver disease: a transient elastography study.1 passage
• Arterial wall structural changes in noncirrhotic chronic hepatitis C patients.1 passage
• Arteriovenous malformations respond poorly to argon plasma coagulation in patients with continuous flow left ventricular assist devices.1 passage
• Artificial intelligence can increase the detection rate of colorectal polyps and adenomas: a systematic review and meta-analysis.1 passage
• Asbestos fibers in the gallbladder of patients affected by benign biliary tract diseases.1 passage
• Ascitic calprotectin for the diagnosis of spontaneous bacterial peritonitis: a systematic review and meta-analysis.1 passage
• Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling.1 passage
• Assessment of adrenal response in patients with stable cirrhosis and ascites using different short Synacthen tests and definitions.1 passage
• Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir.1 passage
• Assessment of liver fibrosis with acoustic radiation force impulse imaging versus liver histology in patients with chronic hepatitis C: a pilot study.1 passage
• Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis.1 passage
• Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.1 passage
• Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.1 passage
• Association between Schatzki ring and eosinophilic esophagitis: a systematic review and meta-analysis.1 passage
• Association between celiac disease and schizophrenia: a meta-analysis.1 passage
• Association between effective hepatic blood flow and the severity and prognosis of hepatitis B virus-related acute on chronic liver failure.1 passage
• Association between high-density lipoprotein cholesterol and apolipoprotein A-I and severe acute pancreatitis: a case-control study.1 passage
• Association between insulin therapy and risk of liver cancer among diabetics: a meta-analysis of epidemiological studies.1 passage
• Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.1 passage
• Association between lower air pressure and the onset of ischemic colitis: a case-control study.1 passage
• Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea.1 passage
• Association between sleep disturbance and multidimensional frailty assessed by Frailty Index in hospitalized cirrhosis.1 passage
• Association of aortic valve disease with intestinal angioectasia: data from the Nationwide Inpatient Sample.1 passage
• Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease.1 passage
• Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction.1 passage
• Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men.1 passage
• Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis.1 passage
• Association of serum vitamin D level and nonalcoholic fatty liver disease: a meta-analysis.1 passage
• Association of smoking with liver fibrosis and mortality in primary biliary cholangitis.1 passage
• Association of the ideal cardiovascular behaviors and factors with the incidence of nonalcoholic fatty liver disease: a prospective study.1 passage
• Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.1 passage
• Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.1 passage
• Atlanta, revised Atlanta, and Determinant-based classification--application in a cohort of Portuguese patients with acute pancreatitis.1 passage
• Attitudes and practice related to Helicobacter pylori infection among primary care physicians.1 passage
• Autoimmune acute liver failure and seronegative autoimmune liver disease in children: Are they different from classical disease?1 passage
• Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.1 passage
• Autoimmune liver disease and concomitant extrahepatic autoimmune disease.1 passage
• Autologous stem cell transplantation for patients with viral hepatitis-induced liver cirrhosis: a systematic review and meta-analysis.1 passage
• Automated low-flow ascites pump in a real-world setting: complications and outcomes.1 passage
• Automatic detection of cirrhosis in hospitalized patients: a pragmatic experience.1 passage
• Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation.1 passage
• BMI history and risk of incident fatty liver: a population-based large-scale cohort study.1 passage
• Bacterial infections in alcoholic and nonalcoholic liver cirrhosis.1 passage
• Bacterial overgrowth and diversification of microbiota in gastric cancer.1 passage
• Bariatric surgery and nonalcoholic fatty liver disease.1 passage
• Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?1 passage
• Baveno-VI clinical staging of cirrhosis under-estimates 5-year survival after variceal bleed in cryptogenic chronic liver disease patients in India.1 passage
• Beliefs and behaviour about smoking among inflammatory bowel disease patients.1 passage
• Biliary stent migration: why, how, and what?1 passage
• Biological response under treatment and prognostic value of protein induced by vitamin K absence or antagonist-II in a French cohort of patients with hepatocellular carcinoma.1 passage
• Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation.1 passage
• Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review.1 passage
• Blue laser imaging: a new image-enhanced endoscopy for the diagnosis of colorectal lesions.1 passage
• Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.1 passage
• Both α-1-antitrypsin Z phenotypes and low caeruloplasmin levels are over-represented in alcohol and nonalcoholic fatty liver disease cirrhotic patients undergoing liver transplant in Ireland.1 passage
• Budesonide treatment for microscopic colitis: systematic review and meta-analysis.1 passage
• Burden of digestive diseases in Portugal: trends in hospitalizations between 2000 and 2010.1 passage
• Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands.1 passage
• C-reactive protein-to-albumin ratio is a predictor of hepatitis B virus related decompensated cirrhosis: time-dependent receiver operating characteristics and decision curve analysis.1 passage
• COVID-19 and liver injury: a meta-analysis.1 passage
• COVID-19 and the liver: overview.1 passage
• COVID-19: gastrointestinal symptoms from the view of gut-lung axis.1 passage
• Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?1 passage
• Can adjusting BMI for age and sex provide for a better predictor of colonic neoplasia?1 passage
• Can infected pancreatic necrosis really be managed conservatively?1 passage
• Can successful treatment by direct-acting antivirals improve depression in chronic HCV patients?1 passage
• Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting.1 passage
• Cannabis in liver disorders: a friend or a foe?1 passage
• Capsule endoscopy is useful diagnostic tool for diagnosing Meckel's diverticulum.1 passage
• Carbohydrate-induced gastrointestinal symptoms: development and validation of a test-specific symptom questionnaire for an adult population, the adult Carbohydrate Perception Questionnaire.1 passage
• Carbon dioxide insufflation during colonoscopy in inflammatory bowel disease patients: a double-blind, randomized, single-center trial.1 passage
• Cardiac dysfunction in patients with cirrhosis: is the systolic component its main feature?1 passage
• Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution.1 passage
• Case series and review of liver dysfunction in COVID-19 patients.1 passage
• Cecal intubation time between cap-assisted water exchange and water exchange colonoscopy: a randomized-controlled trial.1 passage
• Celiac disease is uncommon in irritable bowel syndrome in the USA.1 passage
• Centrilobular zonal necrosis as a hallmark of a distinctive subtype of autoimmune hepatitis.1 passage
• Challenges and obstacles in the transition process through the eyes of the gastroenterologist.1 passage
• Challenging diagnosis of gastrointestinal tuberculosis made simpler with multi-targeted loop-mediated isothermal amplification assay.1 passage
• Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland.1 passage
• Changes in disease behaviour and location and factor analysis in patients with Crohn's disease undergoing repeated-resections.1 passage
• Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.1 passage
• Changes in serum interferon-γ-inducible protein-10 levels and liver stiffness among chronic hepatitis C Egyptian patients in response to directly acting antiviral agents.1 passage
• Changes in the distribution of etiologies of cirrhosis among patients referred for liver transplantation over 11 years in Iran.1 passage
• Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib.1 passage
• Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort.1 passage
• Changing epidemiology of chronic hepatitis C: patients are older and at a more advanced stage at the time of diagnosis.1 passage
• Changing pathological diagnosis from hyperplastic polyp to sessile serrated adenoma: systematic review and meta-analysis.1 passage
• Changing pattern of chronic hepatitis C in renal transplant patients over 20 years.1 passage
• Characterisation of blood microbiota in patients with liver cirrhosis.1 passage
• Characteristics and comorbidities of inpatients without celiac disease on a gluten-free diet.1 passage
• Characteristics and outcome of nosocomial bloodstream infection in patients with acute-on-chronic liver failure.1 passage
• Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.1 passage
• Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.1 passage
• Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment.1 passage
• Characterization of serum irisin in patients with severe acute pancreatitis.1 passage
• Characterizing a cohort of Egyptian patients with acute-on-chronic liver failure.1 passage
• Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn's disease: a systematic review and clinician surveys.1 passage
• Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.1 passage
• Chemerin: a new biomarker to predict postendoscopic retrograde cholangiopancreatography pancreatitis.1 passage
• Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.1 passage
• Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.1 passage
• Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment.1 passage
• Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors.1 passage
• Chronic inflammation and other changes are significant components of clinically fibrotic strictures in Crohn's disease: a histological study of resected strictures clinically characterized as noninflamed.1 passage
• Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector.1 passage
• Chronic severe constipation: current pathophysiological aspects, new diagnostic approaches, and therapeutic options.1 passage
• Circulating endothelial mediators in human pancreatitis-associated lung injury.1 passage
• Circulating methylated RUNX3 and SFRP1 genes as a noninvasive panel for early detection of colorectal cancer.1 passage
• Circulating microRNAs as biomarkers of adult Crohn's disease.1 passage
• Cirrhosis has no impact on therapeutic responses of entecavir for chronic hepatitis B.1 passage
• Clarifying the role of C-reactive protein as a bacterial infection predictor in decompensated cirrhosis.1 passage
• Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus.1 passage
• Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study.1 passage
• Clinical and pathological profile of eosinophilic gastroenteritis.1 passage
• Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study.1 passage
• Clinical application of faecal calprotectin in ulcerative colitis patients.1 passage
• Clinical characteristics and outcome of cirrhotic patients with high protein concentrations in ascites: a prospective study.1 passage
• Clinical characteristics and prognostic factors for Crohn's disease relapses using natural language processing and machine learning: a pilot study.1 passage
• Clinical course and outcome among patients with acute pancreatitis and COVID-19.1 passage
• Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective multicenter cohort study.1 passage
• Clinical efficacy and safety of ketotifen in treating irritable bowel syndrome with diarrhea.1 passage
• Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C.1 passage
• Clinical experience and diagnostic algorithm of vulval Crohn's disease.1 passage
• Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding.1 passage
• Clinical feasibility of panintestinal (or panenteric) capsule endoscopy: a systematic review.1 passage
• Clinical features of liver cirrhosis patients with muscle cramping: a multicenter study.1 passage
• Clinical impact of second-look endoscopy after endoscopic submucosal dissection of gastric neoplasm: a multicenter prospective randomized-controlled trial.1 passage
• Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals.1 passage
• Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study.1 passage
• Clinical outcome of open surgery versus laparoscopic surgery for cirrhotic hepatocellular carcinoma patients: a meta-analysis.1 passage
• Clinical outcomes and healthcare utilization of acute hepatitis A virus infection with acute kidney injury in hospitalized patients.1 passage
• Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study.1 passage
• Clinical practice guidelines from the French National Society of Coloproctology in treating chronic constipation.1 passage
• Clinical predictors and impact of bacteremia in cirrhotic patients with acute skin and skin structure infection.1 passage
• Clinical predictors of Crohn's disease course.1 passage
• Clinical progress of auxiliary liver transplantation.1 passage
• Clinical risk factors for delayed bleeding after endoscopic submucosal dissection for colorectal tumors in Japanese patients.1 passage
• Clinical score predicting a successful endoscopic approach of esophageal anastomotic leaks: external validation.1 passage
• Clinical significance of endothelial progenitor cells in patients with liver cirrhosis with or without hepatocellular carcinoma.1 passage
• Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients.1 passage
• Clinical usefulness and performance of acoustic radiation force impulse in patients with chronic hepatitis B.1 passage
• Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.1 passage
• Clinical utility of double-balloon enteroscopy in suspected Crohn's disease: a single-centre experience.1 passage
• Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.1 passage
• Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice.1 passage
• Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer.1 passage
• Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome.1 passage
• Clinical, psychological, and physiological correlates of patients who defecate after meal.1 passage
• Clinicopathological analysis and risk factors of advanced colorectal neoplasms incidentally detected by 18F-FDG PET-CT.1 passage
• Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia.1 passage
• Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.1 passage
• Clostridium difficile caused changes in fatty acids profile and resolvin D1 content in plasma of infected patients.1 passage
• Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality.1 passage
• Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades.1 passage
• Clostridium septicum liver abscess following colonoscopic stenting of transverse colon cancer.1 passage
• Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes.1 passage
• Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients.1 passage
• Coastal clustering of HEV; Cornwall, UK.1 passage
• Coeliac disease and obstetric and gynaecological disorders: where are we now?1 passage
• Coeliac disease: further evidence that biopsy is not always necessary for diagnosis.1 passage
• Coeliac disease: older patients have the most extensive small bowel involvement on capsule endoscopy.1 passage
• Coexistence of Crohn's disease and systemic lupus erythematosus: a case report and literature review.1 passage
• Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.1 passage
• Cognitive assessment of patients with nonalcoholic fatty liver disease.1 passage
• Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.1 passage
• Colonic carriage of Streptococcus bovis and colorectal neoplasia: a prospective 17-year longitudinal case-control study.1 passage
• Colorectal cancer detection by biomarker quantification in noninvasively collected colorectal mucus: preliminary comparison of 24 protein biomarkers.1 passage
• Colorectal cancer diagnosed during pregnancy: systematic review and treatment pathways.1 passage
• Colorectal cancer in a second round after a negative faecal immunochemical test.1 passage
• Colorectal cancer in young African Americans: clinical characteristics and presentations.1 passage
• Colorectal cancer screening by fecal immunochemical test or colonoscopy in France: how many people are actually covered? Focus on the Provence-Alpes-Côte d'Azur region.1 passage
• Colorectal cancer screening in a low-incidence area: general invitation versus family risk targeting: a comparative study from Montenegro.1 passage
• Colorectal sessile serrated lesion with large size or synchronous neoplasm: a prospective study.1 passage
• Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.1 passage
• Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review.1 passage
• Combined surgery for primary colorectal cancer and synchronous pulmonary metastasis: a pilot experience in two patients.1 passage
• Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia.1 passage
• Combining eastern and western practices for safe and effective endoscopic resection of large complex colorectal lesions.1 passage
• Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis.1 passage
• Combining immune checkpoint inhibitor with lenvatinib prolongs survival than lenvatinib alone in sorafenib-experienced hepatocellular carcinoma patients.1 passage
• Combining the outcomes of endoscopy, laboratory testing, and professional judgement in gastroenterological decision-making.1 passage
• Commonly used biomarkers do not contribute to diagnosing irritable bowel syndrome.1 passage
• Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.1 passage
• Comparative analysis of epidemiology, etiology, and outcomes between elderly and young and middle-aged acute pancreatitis patients: a retrospective, single-center study.1 passage
• Comparative analysis of online patient education material pertaining to hepatitis and its complications.1 passage
• Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels.1 passage
• Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease.1 passage
• Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis.1 passage
• Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis.1 passage
• Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis.1 passage
• Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study.1 passage
• Comparative study of spironolactone and eplerenone in management of ascites in patients of cirrhosis of liver.1 passage
• Comparing endoscopic interventions to improve serrated adenoma detection rates during colonoscopy: a systematic review and network meta-analysis of randomized controlled trials.1 passage
• Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis.1 passage
• Comparing outcomes of stereotactic body radiotherapy with intensity-modulated radiotherapy for patients with locally advanced unresectable pancreatic cancer.1 passage
• Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study.1 passage
• Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation.1 passage
• Comparison of anthropometric measurements for prediction of the atherosclerosis and liver histology in young adults with nonalcoholic fatty liver disease.1 passage
• Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography.1 passage
• Comparison of clinical manifestations and outcomes of noncirrhotic and cirrhotic hepatocellular carcinoma patients with chronic hepatitis B.1 passage
• Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver.1 passage
• Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations.1 passage
• Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.1 passage
• Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease.1 passage
• Comparison of gut-directed hypnotherapy and unspecific hypnotherapy as self-help format in children and adolescents with functional abdominal pain or irritable bowel syndrome: a randomized pilot study.1 passage
• Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy.1 passage
• Comparison of long-term outcomes of balloon angioplasty with or without stent placement for hepatic vein type Budd-Chiari syndrome.1 passage
• Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.1 passage
• Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease.1 passage
• Comparison of patency and cost-effectiveness of self-expandable metal and plastic stents used for malignant biliary strictures: a Polish single-center study.1 passage
• Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.1 passage
• Comparison of risk scores and shock index in hemodynamically stable patients presenting to the emergency department with nonvariceal upper gastrointestinal bleeding.1 passage
• Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study.1 passage
• Comparison of tenofovir and entecavir in the development of acute kidney injury in cirrhotic chronic hepatitis B patients with refractory ascites.1 passage
• Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.1 passage
• Comparison of the impact of tenofovir alafenamide and entecavir on declines of hepatitis B surface antigen levels.1 passage
• Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations - a randomized trial in Latvia.1 passage
• Comparison of transient elastography and Model for End-Stage Liver Disease-sodium to Model for End-Stage Liver Disease-sodium alone to predict mortality and liver transplantation.1 passage
• Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.1 passage
• Competing risks and cause-specific mortality in patients with pancreatic neuroendocrine tumors.1 passage
• Complications and management of elective endoscopic cyanoacrylate injection with lauromacrogol for gastric varices.1 passage
• Compound heterozygous mutations in IL10RA combined with a complement factor properdin mutation in infantile-onset inflammatory bowel disease.1 passage
• Comprehensive analysis of acidic pharyngeal reflux before and after proton pump inhibitor treatment in patients with suspected laryngopharyngeal reflux.1 passage
• Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia.1 passage
• Computer-aided detection of colorectal polyps using a newly generated deep convolutional neural network: from development to first clinical experience.1 passage
• Concomitant decrease of double-positive lymphocyte population CD4CD8αα and Faecalibacterium prausnitzii in patients with colorectal cancer.1 passage
• Concurrent extrahepatic autoimmune disorders: unexplored dimension of autoimmune liver disease in children.1 passage
• Consensus document on the management preferences of patients with ulcerative colitis: points to consider and recommendations.1 passage
• Constipation in critical care patients: both timing and duration matter.1 passage
• Constipation incidence and impact in medical critical care patients: importance of the definition criterion.1 passage
• Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis.1 passage
• Continuous insulin therapy versus apheresis in patients with hypertriglyceridemia-associated pancreatitis.1 passage
• Controlled attenuation parameter for diagnosing steatosis in bariatric surgery candidates with suspected nonalcoholic fatty liver disease.1 passage
• Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.1 passage
• Controversial risk factors for cholangiocarcinoma.1 passage
• Conventional clinical and pathological features fail to accurately predict recurrence in patients with gastric cancer staged N0.1 passage
• Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease.1 passage
• Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals: a pilot study.1 passage
• Correlations between the serum bilirubin level and ulcerative colitis: a case-control study.1 passage
• Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience.1 passage
• Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma.1 passage
• Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece.1 passage
• Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.1 passage
• Criteria for difficult biliary cannulation: start to count.1 passage
• Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy.1 passage
• Cry wolf and inflate medical urgency to expedite consult resolution through gastrointestinal endoscopy.1 passage
• Cryoballoon ablation as salvage therapy after nonradical resection of a high-risk T1b esophageal adenocarcinoma: a case report.1 passage
• Current health status and medical therapy of patients with pediatric-onset inflammatory bowel disease: a survey-based analysis on 1280 patients aged 10-25 years focusing on differences by age of onset.1 passage
• Current use of MRI in patients with liver metastatic colorectal cancer: a population-based study.1 passage
• Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots.1 passage
• Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience.1 passage
• DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn's disease.1 passage
• Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients.1 passage
• De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors.1 passage
• De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients.1 passage
• De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.1 passage
• De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus.1 passage
• Decision making and outcome of pregnancies in female patients with inflammatory bowel disease: findings from a community-based practice.1 passage
• Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.1 passage
• Decrease of trabecular bone score reflects severity of Crohn's disease: results of a case-control study.1 passage
• Decreased number of colonic tuft cells in quiescent ulcerative colitis patients.1 passage
• Deep learning enabled classification of Mayo endoscopic subscore in patients with ulcerative colitis.1 passage
• Delayed diagnosis is influenced by the clinical pattern of Crohn's disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy.1 passage
• Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.1 passage
• Depression and insomnia among individuals with celiac disease or on a gluten-free diet in the USA: results from a national survey.1 passage
• Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.1 passage
• Design and verification of individualized follow-up strategy of colonoscopy for postoperative patients with colorectal cancer.1 passage
• Detachable string magnetically controlled capsule endoscopy for complete observation of the upper gastrointestinal tract.1 passage
• Detection of hepatitis C virus core antigen as an alternative method for diagnosis of hepatitis C virus infection in blood donors negative for hepatitis C virus antibody.1 passage
• Detection of molecular bacterascites in decompensated cirrhosis defines a risk with decreased survival.1 passage
• Determinants of long-term complications of endoscopic sphincterotomy are infections and high risk factors of bile duct and not sphincter of Oddi dysfunction.1 passage
• Developing a better biopsychosocial understanding of pain in inflammatory bowel disease: a cross-sectional study.1 passage
• Development and evaluation of a novel noninvasive index for predicting significant fibrosis, advanced fibrosis, and cirrhosis in patients with chronic hepatitis B infection.1 passage
• Development and initial validation of a disease-specific bowel continence questionnaire for inflammatory bowel disease patients: the ICIQ-IBD.1 passage
• Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure.1 passage
• Development and validation of a scoring index to predict the presence of lesions in capsule endoscopy in patients with suspected Crohn's disease of the small bowel: a Spanish multicenter study.1 passage
• Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding.1 passage
• Development of the Irritable Bowel Syndrome Cognitive Affective Scale: a brief self-report measure for clinical and research settings.1 passage
• Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients.1 passage
• Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.1 passage
• Diabetic status and grade of nonalcoholic fatty liver disease are associated with lower baroreceptor sensitivity in patients with nonalcoholic fatty liver disease.1 passage
• Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.1 passage
• Diagnostic accuracy of confocal laser endomicroscopy for the characterization of liver nodules.1 passage
• Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.1 passage
• Diagnostic accuracy of different noninvasive scores for detecting advanced fibrosis in chronic hepatitis B.1 passage
• Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn's disease.1 passage
• Diagnostic accuracy of γ-glutamyl transpeptidase-to-platelet ratio for predicting hepatitis B-related fibrosis: a meta-analysis.1 passage
• Diagnostic and therapeutic yields of urgent balloon-assisted enteroscopy in overt obscure gastrointestinal bleeding.1 passage
• Diagnostic confidence of computed tomography and magnetic resonance in focal liver pathology.1 passage
• Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score.1 passage
• Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.1 passage
• Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.1 passage
• Diagnostic performance of extrinsic apoptosis pathway in hepatitis C virus patients: apoptosis fibrosis crosstalk.1 passage
• Diagnostic performance of real-time tissue elastography in chronic hepatitis C patients with sustained virological response.1 passage
• Diagnostic significance of cytomegalovirus DNA quantitation in gastrointestinal biopsies: comparison with histopathological data and blood cytomegalovirus DNA.1 passage
• Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease.1 passage
• Diagnostic utility of interferon gamma-induced protein 10 kDa in spontaneous bacterial peritonitis: single-center study.1 passage
• Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease.1 passage
• Differences between sporadic hyperplastic gastric polyps and portal hypertensive gastric polyps: a review.1 passage
• Differences in amino acid and lipid metabolism distinguish Crohn's from idiopathic/cryptoglandular perianal fistulas by tissue metabonomic profiling and may offer clues to underlying pathogenesis.1 passage
• Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.1 passage
• Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens.1 passage
• Differential diagnosis of hypoalbuminemia in childhood: protein losing enteropathy associated to systemic lupus erythematosus in a young boy.1 passage
• Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role?1 passage
• Direct antiviral drugs in the treatment of hepatitis C-infected rheumatoid arthritis Egyptian cohort: safety and clinical impact.1 passage
• Direct-acting antiviral hepatitis C virus treatment perturbation of the metabolic milieu.1 passage
• Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients.1 passage
• Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries.1 passage
• Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.1 passage
• Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies.1 passage
• Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.1 passage
• Distinct patterns of short-chain fatty acids during flare in patients with ulcerative colitis under treatment with mesalamine or a herbal combination of myrrh, chamomile flowers, and coffee charcoal: secondary analysis of a randomized controlled trial.1 passage
• Diverse correlations between fibrosis-related factors and liver stiffness measurement by transient elastography in chronic hepatitis B.1 passage
• Diverticular disease as a chronic gastrointestinal condition: experience from a specialist clinic.1 passage
• Do we need to screen for de-novo diabetes mellitus in chronic hepatitis C patients after a sustained virological response?1 passage
• Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis.1 passage
• Does gallbladder wall thickness measurement predict esophageal varices in cirrhotic patients with portal hypertension?1 passage
• Does melatonin addition to indomethacin decrease post endoscopic retrograde cholangiopancreatography pancreatitis? A randomized double-blind controlled trial.1 passage
• Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn's disease patients: a meta-analysis.1 passage
• Does timing of endoscopy affect outcomes in patients with upper gastrointestinal bleeding: a systematic review and meta-analysis.1 passage
• Dose-dependent effect of propranolol on the hemodynamic response in cirrhotic patients with gastroesophageal varices.1 passage
• Double plastic stenting for inoperable malignant biliary stricture among cirrhotic patients as a possible cost-effective treatment: a pilot study.1 passage
• Dual biologic therapy with Vedolizumab and Ustekinumab for refractory Crohn's disease in children.1 passage
• Dual-layer spectral detector computed tomography versus magnetic resonance cholangiopancreatography for biliary stones.1 passage
• Duodenal cryptococcus infection in an AIDS patient: retrospective clinical analysis.1 passage
• Duodenal histopathology and laboratory deficiencies related to bone metabolism in coeliac disease.1 passage
• Dynamic prediction of liver cirrhosis risk in chronic hepatitis B patients using longitudinal clinical data.1 passage
• Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B.1 passage
• ESPGHAN 'biopsy-sparing' guidelines for celiac disease in children with low antitransglutaminase during COVID-19.1 passage
• Early and late surgical outcomes of ileal pouch-anal anastomosis within a defined population in Sweden.1 passage
• Early detection of hepatocellular carcinoma in patients with diabetes mellitus.1 passage
• Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers.1 passage
• Early detection of sporadic pancreatic cancer: time for change.1 passage
• Early effects of Roux-en-Y gastric bypass on peptides and hormones involved in the control of energy balance.1 passage
• Early histopathologic changes in primary biliary cholangitis: does 'minimal change' primary biliary cholangitis exist? A pathologist's view.1 passage
• Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs.1 passage
• Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA.1 passage
• Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis.1 passage
• Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials.1 passage
• Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance.1 passage
• Early weight changes after liver transplantation significantly impact patient and graft survival.1 passage
• Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps.1 passage
• Effect of WeChat and short message service on bowel preparation: an endoscopist-blinded, randomized controlled trial.1 passage
• Effect of abdominal visceral fat on the development of new erosive oesophagitis: a prospective cohort study.1 passage
• Effect of acute upper gastrointestinal bleeding manifestations at admission on the in-hospital outcomes of liver cirrhosis: hematemesis versus melena without hematemesis.1 passage
• Effect of adding daclatasvir in sofosbuvir-based therapy in genotype 3 hepatitis C: real-world experience in Pakistan.1 passage
• Effect of alpha agonists on the prevention of postparacentesis circulatory dysfunction in patients with refractory or recurrent ascites: a meta-analysis.1 passage
• Effect of branched-chain amino acid supplements on muscle strength and muscle mass in patients with liver cirrhosis.1 passage
• Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.1 passage
• Effect of disease stage and treatment outcomes on the dynamics of liver functions during and after treatment of hepatitis C with directly acting antivirals.1 passage
• Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece.1 passage
• Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.1 passage
• Effect of nutritional risk on short-term outcomes after laparoscopic-assisted gastrectomy: a prospective study from two centers.1 passage
• Effect of psychosocial stressors on patients with Crohn's disease: threatening life experiences and family relations.1 passage
• Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis.1 passage
• Effect of threatening life experiences and adverse family relations in ulcerative colitis: analysis using structural equation modeling and comparison with Crohn's disease.1 passage
• Effectiveness and safety of endoscopic treatment for duodenal variceal bleeding: a systematic review.1 passage
• Effectiveness of 8-week sofosbuvir/ledipasvir in the adolescent chronic hepatitis C-infected patients.1 passage
• Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.1 passage
• Effectiveness of combined therapy radiofrequency ablation/transarterial chemoembolization versus transarterial chemoembolization/radiofrequency ablation on management of hepatocellular carcinoma.1 passage
• Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role?1 passage
• Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences.1 passage
• Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study.1 passage
• Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis.1 passage
• Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.1 passage
• Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.1 passage
• Effects of dietary education, followed by a tailored fructose-restricted diet in adults with fructose malabsorption.1 passage
• Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis.1 passage
• Effects of introduction of an inflammatory bowel disease nurse position on the quality of delivered care.1 passage
• Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single center.1 passage
• Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.1 passage
• Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study.1 passage
• Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis.1 passage
• Efficacy and safety of a capsule endoscope delivery device in children.1 passage
• Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.1 passage
• Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.1 passage
• Efficacy and safety of direct-acting antivirals in older patients with cirrhosis and high comorbidity index.1 passage
• Efficacy and safety of endoscopic resection techniques of large colorectal lesions: experience of a referral center in Italy.1 passage
• Efficacy and safety of primary needle-knife fistulotomy in biliary cannulation: a systematic review and meta-analysis.1 passage
• Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem.1 passage
• Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.1 passage
• Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis.1 passage
• Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.1 passage
• Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases.1 passage
• Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome.1 passage
• Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.1 passage
• Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.1 passage
• Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.1 passage
• Efficacy of endoscopic triage during the Covid-19 outbreak and infective risk.1 passage
• Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.1 passage
• Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.1 passage
• Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.1 passage
• Efficacy of puncturing different portal vein branch during transjugular intrahepatic portosystemic shunt with 8 mm covered stent: a propensity-score analysis.1 passage
• Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.1 passage
• Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.1 passage
• Efficacy of sofosbuvir/velpatasvir/voxilaprevir in direct-acting antiviral experienced patients with hepatitis C virus.1 passage
• Efficiency of azathioprine monotherapy for maintenance treatment of autoimmune hepatitis in children.1 passage
• Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis C.1 passage
• Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.1 passage
• Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab.1 passage
• Elevated mean platelet volume to platelet ratio predicts advanced fibrosis in chronic hepatitis C.1 passage
• Elevated platelet distribution width and red cell distribution width are associated with autoimmune liver diseases.1 passage
• Elevated procalcitonin is associated with bacterial infection during acute liver failure only when unrelated to acetaminophen intoxication.1 passage
• Elevated serum procalcitonin levels and their association with the prognosis of patients with liver cirrhosis.1 passage
• Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.1 passage
• Emergency readmission following acute upper gastrointestinal bleeding.1 passage
• Emerging trends and risk factors for perianal surgery in Crohn's disease: a 20-year national population-based cohort study.1 passage
• Employment status, difficulties at work and quality of life in inflammatory bowel disease patients.1 passage
• Endocannabinoid system and cannabis hyperemesis syndrome: a narrative update.1 passage
• Endoscopic and histologic evaluation of the gastrointestinal tract in patients with sarcoidosis.1 passage
• Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.1 passage
• Endoscopic appearances of polypoid type 1 gastric microcarcinoids by narrow-band imaging: a case series in a referral center.1 passage
• Endoscopic band ligation versus endoscopic hemoclip placement for Dieulafoy's lesion: a meta-analysis.1 passage
• Endoscopic drainage in patients with malignant extrahepatic biliary obstruction: when and how.1 passage
• Endoscopic full thickness resection in the colo-rectum: outcomes from the UK Registry.1 passage
• Endoscopic management of Barrett's dysplasia and early neoplasia: efficacy, safety and long-term outcomes in a UK tertiary centre.1 passage
• Endoscopic mucosal resection of large colonic laterally spreading tumors using a dedicated viscous solution for submucosal injection (ORISE gel): a short case series (with video).1 passage
• Endoscopic radiofrequency ablation for the treatment of severe gastric antral vascular ectasia in patients with cirrhosis.1 passage
• Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label.1 passage
• Endoscopic resection of early squamous neoplasia of the oesophagus: long-term follow-up in a UK population from a tertiary hospital.1 passage
• Endoscopic sedation and monitoring practices in Portugal: a nationwide web-based survey.1 passage
• Endoscopic stenting for palliation of intra-abdominal gastrointestinal malignant obstruction: predictive factors for clinical success.1 passage
• Endoscopic submucosal dissection of gastric neoplastic lesions in Western countries: systematic review and meta-analysis.1 passage
• Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg.1 passage
• Endoscopic treatment for patients with gastric outlet stricture and biliary obstruction in the absence of endoscopic ultrasound: a retrospective study.1 passage
• Endoscopic ultrasonography-fine needle aspiration versus PET-CT in undiagnosed mediastinal and upper abdominal lymphadenopathy: a comparative clinical study.1 passage
• Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis with a lumen-apposing metal stent: a systematic review of case series.1 passage
• Endoscopic ultrasound-guided liver biopsy using a 20-gauge fine needle biopsy needle with the wet-heparinized suction technique.1 passage
• Endoscopic ultrasound-guided sampling of gastrointestinal subepithelial lesions: just wet it.1 passage
• Endoscopic variceal ligation combined with argon plasma coagulation versus ligation alone for the secondary prophylaxis of variceal bleeding: a systematic review and meta-analysis.1 passage
• Endoscopist-directed propofol is more efficient than anesthesiologist-administered propofol in patients at low-intermediate anesthetic risk.1 passage
• Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt.1 passage
• Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.1 passage
• Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis.1 passage
• Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safety.1 passage
• Entecavir as a first-line treatment for hepatitis B virus reactivation following polychemotherapy for chronic lymphocytic leukemia and invasive ductal carcinoma: a report of two cases and review of the literature.1 passage
• Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities.1 passage
• Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.1 passage
• Environmental exposures and the risk of inflammatory bowel disease: a case-control study from Saudi Arabia.1 passage
• Eosinophilic gastrointestinal disease and inflammatory bowel disease in children: is it a disease continuum?1 passage
• Epidemiological approximation of the enteric manifestation and possible fecal-oral transmission in COVID-19: a preliminary systematic review.1 passage
• Epidemiology of atrial fibrillation in patients with cirrhosis and clinical significance: a meta-analysis.1 passage
• Epidemiology of hepatitis B in Portugal.1 passage
• Epidemiology of intrahepatic, perihilar, and distal cholangiocarcinoma in the French population.1 passage
• Epidemiology of pancreatic cancer in France: descriptive study from the French national hospital database.1 passage
• Epigenetic-sensitive challenges of cardiohepatic interactions: clinical and therapeutic implications in heart failure patients.1 passage
• Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis.1 passage
• Esophageal foreign bodies: observational cohort study and factors associated with recurrent impaction.1 passage
• Esophageal involvement is frequent in lichen planus: study in 32 patients with suggestion of clinicopathologic diagnostic criteria and therapeutic implications.1 passage
• Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma.1 passage
• Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization.1 passage
• Estimation of glomerular filtration rate in patients with cirrhosis: evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate.1 passage
• Estrogen receptor β expression and colorectal cancer: a systematic review and meta-analysis.1 passage
• Ethnic variation in colorectal cancer risk following a positive faecal occult blood test in an English bowel cancer screening programme centre.1 passage
• Ethnicity influences pain after ultrasound-guided percutaneous liver biopsy.1 passage
• Etiological factors of chronic hepatitis in Italy: a 2014 national survey.1 passage
• European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.1 passage
• Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients.1 passage
• Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.1 passage
• Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.1 passage
• Evaluation of esophageal motility after endoscopic submucosal dissection for superficial esophageal cancer.1 passage
• Evaluation of hepatitis B vaccine efficacy and factors affecting vaccine nonresponse in patients receiving anti-tumor necrosis factor agents.1 passage
• Evaluation of liver fibrosis in patients with Wilson's disease.1 passage
• Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma.1 passage
• Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.1 passage
• Evaluation of prognostic value of neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure or severe liver injury from chronic HBV infection.1 passage
• Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B.1 passage
• Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.1 passage
• Evaluation of the efficacy and safety of direct oral anticoagulants in the treatment of portal vein thrombosis.1 passage
• Evolution in clinical presentation of inflammatory bowel disease over time at diagnosis: a multicenter cohort study.1 passage
• Examining predictors of healthcare utilization in youth with inflammatory bowel disease.1 passage
• Exploration of interventional therapy strategy for portal vein occlusion: a case series study.1 passage
• Exploring and predicting mortality among patients with end-stage liver disease without cancer: a machine learning approach.1 passage
• Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies.1 passage
• Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection.1 passage
• External validation of the Toronto hepatocellular carcinoma risk index in Turkish cirrhotic patients.1 passage
• Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance.1 passage
• Extrapancreatic infections are common in acute pancreatitis and they are related to organ failure: a population-based study.1 passage
• FIB-4 and imaging for measuring fibrosis in hepatitis C virus.1 passage
• Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experience.1 passage
• Factors associated with anxiety and depressive symptoms in colorectal cancer survivors.1 passage
• Factors associated with impaired quality of life in French patients with chronic idiopathic constipation: a cross-sectional study.1 passage
• Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.1 passage
• Factors influencing health-related quality of life in patients with Barrett's esophagus: a qualitative focus group study.1 passage
• Factors related to colorectal cancer in advanced adenomas and serrated polyps: a further step toward individualized surveillance.1 passage
• Factors related to increased resting energy expenditure in men with liver cirrhosis.1 passage
• Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis.1 passage
• Faecal calprotectin levels in children with Henoch-Schönlein purpura: is this a new marker for gastrointestinal involvement?1 passage
• Faecal microbiota transplantation: establishment of a clinical application framework.1 passage
• Faecal microbiota transplantation: what's beyond Clostridium difficile infection?1 passage
• Family history, comorbidity, smoking and other risk factors in microscopic colitis: a case-control study.1 passage
• Family planning in inflammatory bowel disease: childlessness and disease-related concerns among female patients.1 passage
• Favorable liver cancer mortality-to-incidence ratios of countries with high health expenditure.1 passage
• Feasibility and learning curve of unsupervised colorectal endoscopic submucosal hydrodissection at a Western Center.1 passage
• Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases.1 passage
• Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.1 passage
• Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.1 passage
• Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn's disease.1 passage
• Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment.1 passage
• Fecal neopterin level determination: can be a useful screening test for colorectal polyps?1 passage
• Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease.1 passage
• Fibrosis improvement in patients with HCV treated with direct-acting antivirals.1 passage
• Fibrosis scores that can be used in follow-up of after direct-acting antiviral treatment: APRI, FIB-4, King score and GUCI.1 passage
• Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.1 passage
• Finger clubbing in inflammatory bowel disease: association with upper small bowel lesions and need of surgery in Crohn's disease.1 passage
• Five-year-term results in cirrhotics without varices, either affected or not by portal hypertensive gastropathy.1 passage
• Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.1 passage
• Fluoroquinolone-resistant strains in cirrhotic patients with spontaneous bacterial peritonitis: microbiological and molecular aspects.1 passage
• Fontan-associated liver disease: pathophysiology, investigations, predictors of severity and management.1 passage
• Forecasting the disease burden of chronic hepatitis C virus in Poland.1 passage
• Fracture risk calculation tool enhances dual-energy X-ray absorptiometry scan referral pathway in cirrhosis patients.1 passage
• Fragility index: how fragile is the data that support the American College of Gastroenterology guidelines for the management of Crohn's disease?1 passage
• Frailty is strongly associated with self-reported symptom burden among patients with cirrhosis.1 passage
• French experience with telemedicine in inflammatory bowel disease: a patients and physicians survey.1 passage
• Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.1 passage
• Frequency distribution and risk factors of hepatitis B virus and hepatitis C virus infections among thalassemia patients: a regional study.1 passage
• From first-generation hepatitis C virus protease inhibitors to direct-acting antivirals: self-reported symptoms as a warning signal for potential adverse events (ANRS HC26, ANRS HC27 trials).1 passage
• From terminal ileitis to Crohn's disease: how capsule endoscopy is crucial to diagnosis.1 passage
• Fully Covered Self-Expandable Metal Stens eliminate surgical repair requirement in both endoscopic sphincterotomy and precut sphincterotomy-related perforation (with video).1 passage
• Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.1 passage
• Functional dyspepsia is associated with GNβ3 C825T and CCK-AR T/C polymorphism.1 passage
• Functional gastrointestinal disorders as predictors of suicidal ideation. An observational study.1 passage
• Gallstones are associated with hidradenitis suppurativa: a population-based and hospital-based cross-sectional study from Denmark.1 passage
• Gallstones in childhood: etiology, clinical features, and prognosis.1 passage
• Gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: CTLA-4 deficiency successfully treated with Abatacept.1 passage
• Gastric endoscopic submucosal dissection: a systematic review and meta-analysis on risk factors for poor short-term outcomes.1 passage
• Gastritis staging as a clinical priority.1 passage
• Gastro-oesophageal reflux disease and dental erosions in adults: influence of acidified food intake and impact on quality of life.1 passage
• Gastro-oesophageal reflux symptoms and coeliac disease: no role for routine duodenal biopsy.1 passage
• Gastroenterologists' preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey.1 passage
• Gastroesophageal Reflux Disease - Health-Related Quality of Life Questionnaire: prospective development and validation in Italian.1 passage
• Gastrointestinal endoscopy can be safely performed during pandemic SARS-CoV-2 infection in Central Italy.1 passage
• Gastrointestinal manifestations of COVID-19: results from a European centre.1 passage
• Gastrointestinal manifestations of angioedema: a potential area of misdiagnosis.1 passage
• Gastrointestinal recall questionnaires compare poorly with prospective patient diaries for gastrointestinal symptoms: data from population and primary health centre samples.1 passage
• Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis.1 passage
• Gastroscopy in younger patients: an analysis of referrals and pathologies.1 passage
• Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease.1 passage
• Genetic polymorphisms present in IL10, IL23R, NOD2, and ATG16L1 associated with susceptibility to inflammatory bowel disease in Mexican population.1 passage
• Genetic variants of tissue inhibitors of matrix metalloproteinase 1 (rs4898) and 2 (rs8179090) in diverticulosis.1 passage
• Genome-wide DNA methylation profiling and gut flora analysis in intestinal polyps patients.1 passage
• Geographical variance in reporting of elective surgery for chronic pancreatitis.1 passage
• Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase.1 passage
• Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression.1 passage
• Glypican-3 and hepatocyte paraffin-1 combined with alpha-fetoprotein as a novel risk scoring model for predicting early recurrence of hepatocellular carcinoma after curative resection.1 passage
• Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis.1 passage
• Graft-versus-host disease after living donor liver transplantation: an unpredictable troublesome complication for liver transplant centers.1 passage
• Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial.1 passage
• Guided self-help interventions for irritable bowel syndrome: a systematic review and meta-analysis.1 passage
• Gut colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae may increase disease activity in biologic-naive outpatients with ulcerative colitis: an interim analysis.1 passage
• Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus.1 passage
• HBV-related acute-on-chronic liver failure with underlying chronic hepatitis has superior survival compared to cirrhosis.1 passage
• Healthcare practitioners' diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey.1 passage
• Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review.1 passage
• Helicobacter pylori infection among patients with liver cirrhosis.1 passage
• Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study.1 passage
• Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.1 passage
• Heme is involved in the systemic inflammatory response following radiofrequency ablation of hepatic hemangiomas.1 passage
• Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis.1 passage
• Hepascore and hyaluronic acid as markers of fibrosis in liver disease of mixed aetiology.1 passage
• Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients.1 passage
• Hepatic progenitor cells in children with chronic hepatitis C: correlation with histopathology, viremia, and treatment response.1 passage
• Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference.1 passage
• Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study.1 passage
• Hepatic veno-occlusive disease development in the hematopoietic stem cell transplantation patients: incidence and associated risk factors, a meta-analysis.1 passage
• Hepatitis A hospitalizations among kidney transplant recipients in the United States: nationwide inpatient sample 2005-2014.1 passage
• Hepatitis A seroprevalence in patients with chronic viral hepatitis in Konya, Turkey.1 passage
• Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.1 passage
• Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients.1 passage
• Hepatitis B virus infection and risk of gallstones: a systematic review and meta-analysis.1 passage
• Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink.1 passage
• Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.1 passage
• Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.1 passage
• Hepatitis C and hepatitis C-related advanced liver disease hospitalisation trends before and after the Strategic Plan for Tackling Hepatitis C in the National Health System.1 passage
• Hepatitis C in a Mobile Low-Threshold Methadone Program.1 passage
• Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).1 passage
• Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R).1 passage
• Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis.1 passage
• Hepatitis C virus infection: opportunities for an earlier detection in primary care.1 passage
• Hepatitis C virus treatment by direct-acting antivirals in successfully treated hepatocellular carcinoma and possible mutual impact.1 passage
• Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit.1 passage
• Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?1 passage
• Hepatitis E virus infection in liver transplant recipients: a descriptive literature review.1 passage
• Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.1 passage
• Hepatocellular carcinoma in noncirrhotic livers is associated with steatosis rather than steatohepatitis: potential implications for pathogenesis.1 passage
• Hepatocellular carcinoma in patients coinfected with hepatitis B or C and HIV: more aggressive tumor behavior?1 passage
• Hepatocellular carcinoma in the noncirrhotic liver: a literature review.1 passage
• Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.1 passage
• Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival.1 passage
• Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study.1 passage
• Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.1 passage
• Hepatopulmonary syndrome delays postoperative recovery and increases pulmonary complications after hepatectomy.1 passage
• Herbal medicines for the liver: from bench to bedside.1 passage
• Hereditary hemochromatosis and risk of joint replacement surgery: a systematic review and meta-analysis.1 passage
• Heritability analysis of liver stiffness detected by ultrasound shear wave elastography: a twin study.1 passage
• High frequency of gastric cancer precursor lesions in patients with gastric xanthelasma: a prospective case-control study.1 passage
• High frequency of secondary, but not primary ocular manifestations of inflammatory bowel disease in patients treated at a tertiary care center.1 passage
• High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.1 passage
• High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.1 passage
• High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany.1 passage
• High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.1 passage
• High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands.1 passage
• High rate of acute pancreatitis during the Ramadan fast.1 passage
• High rates of ineligibility for participation in trials of new therapies in non-alcoholic steatohepatitis: a systematic review.1 passage
• High rates of serology testing for coeliac disease, and low rates of endoscopy in serologically positive children and adults in Israel: lessons from a large real-world database.1 passage
• High sustained virologic response rate using generic directly acting antivirals in the treatment of chronic hepatitis C virus Egyptian patients: single-center experience.1 passage
• High variation in treatment strategies for gastrointestinal angiodysplasias.1 passage
• High-definition i-Scan colonoscopy is superior in the detection of diminutive polyps compared with high-definition white light colonoscopy: a prospective randomized-controlled trial.1 passage
• Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients.1 passage
• Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.1 passage
• Higher odds of irritable bowel syndrome among hospitalized patients using cannabis: a propensity-matched analysis.1 passage
• Higher quality of life after metal stent placement compared with plastic stent placement for malignant extrahepatic bile duct obstruction: a randomized controlled trial.1 passage
• Histologic types of gastric cancer among migrants from the former Soviet Union and the general population in Germany: what kind of prevention do we need?1 passage
• Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing.1 passage
• Histological variety of gastric carcinoma and Helicobacter pylori cagA and vacA polymorphism.1 passage
• Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.1 passage
• Homeostasis model assessment of insulin resistance and lobular inflammation in nondiabetic patients with nonalcoholic fatty liver disease: methodological considerations.1 passage
• Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver disease.1 passage
• Homocysteine: a new diagnostic marker in spontaneous bacterial peritonitis.1 passage
• How to best measure quality of life in coeliac disease? A validation and comparison of disease-specific and generic quality of life measures.1 passage
• How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and responsibilities beyond the liver specialist.1 passage
• Human mesenchymal stem cells for hepatitis B virus-related acute-on-chronic liver failure: a systematic review with meta-analysis.1 passage
• Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease.1 passage
• Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis.1 passage
• Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.1 passage
• Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.1 passage
• Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.1 passage
• Hypoglycemia is an early, independent predictor of bacteremia and in-hospital death in patients with cirrhosis.1 passage
• IL-10-1082G>A polymorphism, use of opioids and age affect the course of acute pancreatitis.1 passage
• Identification of patients at risk for colorectal cancer in primary care: an explorative study with routine healthcare data.1 passage
• Identification of prognostic factors in early stage low rectal cancer to optimize surgical treatment; local excision or abdominoperineal resection.1 passage
• Identification of upper gastrointestinal malignancy in patients with uncomplicated dyspepsia referred under the two-week-wait cancer pathway: a single-centre, 10-year experience.1 passage
• Identifying characteristics of drug-related problems in critically ill patients with decompensated liver cirrhosis.1 passage
• Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.1 passage
• Identifying predictors of low adherence in patients with inflammatory bowel disease.1 passage
• IgE antibodies and skin tests in immediate hypersensitivity reactions to infliximab in inflammatory bowel disease: impact on infliximab retreatment.1 passage
• Ignorance isn't bliss: why patients become angry.1 passage
• Immune monitoring of a child with autoimmune hepatitis and type 1 diabetes during COVID-19 infection.1 passage
• Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management.1 passage
• Immunosuppressive drug withdrawal late after liver transplantation improves the lipid profile and reduces infections.1 passage
• Impact of HCV cure with drug-acting antivirals in the use of concomitant medication and lipid profile: follow-up data 2 years after the sustained virological response.1 passage
• Impact of acute-on-chronic liver failure on post-transplant survival and on kidney outcomes.1 passage
• Impact of caffeine in hepatitis C virus infection: a systematic review and meta-analysis.1 passage
• Impact of cardiac dysfunction on health-related quality of life in cirrhotic liver transplant candidates.1 passage
• Impact of demographic and clinical parameters on video capsule transit time.1 passage
• Impact of direct-acting antivirals on leukocytic DNA telomere length in hepatitis C virus-related hepatic cirrhosis.1 passage
• Impact of donor sodium levels on clinical outcomes in liver transplant recipients: a systematic review.1 passage
• Impact of endoscopic ultrasonography (EUS) and EUS-guided fine-needle aspiration on the management of pancreatic cystic lesions.1 passage
• Impact of endoscopic ultrasound-guided fine-needle aspiration and multidisciplinary approach in the management of abdominal or mediastinal mass.1 passage
• Impact of endoscopist experience, patient age and comorbidities on dose of sedation and sedation-related complications by endoscopic ultrasound.1 passage
• Impact of gastroesophageal reflux disease symptoms on the quality of life in pregnant women: a prospective study.1 passage
• Impact of immigration in presentation and outcomes of hepatocellular carcinoma in the USA.1 passage
• Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.1 passage
• Impact of interferon-free therapies in HIV/HCV co-infected patients on real clinical practice: results from a multicenter region-wide cohort study (2014-2018).1 passage
• Impact of laparoscopic cholecystectomy on the complexity of endoscopic retrograde cholangiopancreatography.1 passage
• Impact of new direct-acting antiviral drugs on hepatitis C virus-related decompensated liver cirrhosis.1 passage
• Impact of nitazoxanide on sustained virologic response in Egyptian patients with chronic hepatitis C genotype 4: a double-blind placebo-controlled trial.1 passage
• Impact of occupational stress on irritable bowel syndrome pathophysiology and potential management in active duty noncombat Greek military personnel: a multicenter prospective survey.1 passage
• Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.1 passage
• Impact of steatosis and inflammation definitions on the performance of NASH tests.1 passage
• Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis.1 passage
• Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir.1 passage
• Implementing capnography to help improve patient safety during procedural sedation: quality improvement in a high-volume gastroenterology department.1 passage
• Implications of COVID-19 for the busy gastroenterologist.1 passage
• Improved outcomes with surgery compared to radiofrequency ablation in the treatment of resectable hepatocellular carcinoma.1 passage
• Improvement of clinical management and outcome in hepatocellular carcinoma nowadays compared with historical cohorts.1 passage
• Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin.1 passage
• Improving diagnostic yield in obscure gastrointestinal bleeding--how virtual chromoendoscopy may be the answer.1 passage
• Improving prognosis for patients with hepatocellular carcinoma in Ireland 1994-2008.1 passage
• Improving testing for hepatitis B before treatment with rituximab.1 passage
• Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.1 passage
• Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.1 passage
• Incidence and predictors of adenoma after surgery for colorectal cancer.1 passage
• Incidence and risk factors for 30-day readmission in ulcerative colitis: nationwide analysis in biologic era.1 passage
• Incidence of kidney cancer after liver transplantation: a meta-analysis.1 passage
• Incidence of metachronous gastric cancer after endoscopic submucosal dissection associated with eradication status of Helicobacter pylori.1 passage
• Incidence of renal cell carcinoma in inflammatory bowel disease patients with and without anti-TNF treatment.1 passage
• Incidence of spontaneous bacterial peritonitis among asymptomatic cirrhosis patients undergoing outpatient paracentesis: a systematic review and meta-analysis.1 passage
• Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study.1 passage
• Incidences of hypothyroidism and autoimmune thyroiditis are increased in patients with nonalcoholic fatty liver disease.1 passage
• Incident heart failure is a predictor of adverse outcomes in inflammatory bowel disease.1 passage
• Increased abdominal fat levels measured by bioelectrical impedance are associated with histological lesions of nonalcoholic steatohepatitis.1 passage
• Increased arterial stiffness and its relationship with inflammation, insulin, and insulin resistance in celiac disease.1 passage
• Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis.1 passage
• Increased liver stiffness by transient elastography and acoustic radiation force impulse imaging in patients with extrahepatic cholestasis.1 passage
• Increased mean platelet volume is related to histologic severity of primary biliary cirrhosis.1 passage
• Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine.1 passage
• Increased odds of cholangiocarcinoma in Hispanics: results of a nationwide analysis.1 passage
• Increased prevalence of heparin-induced thrombocytopenia in patients with Budd-Chiari syndrome: a retrospective analysis.1 passage
• Increased prevalence of irritable bowel syndrome in migraine patients: a systematic review and meta-analysis.1 passage
• Increased prevalence of portal vein thrombosis in patients with nonalcoholic steatohepatitis-cirrhosis due to increased proinflammatory cytokines releasing from abdominal adipose tissue.1 passage
• Increased prevalence of restless legs syndrome in patients with Crohn's disease.1 passage
• Increased rates of spinal fusion surgery in patients with hereditary hemochromatosis: a five-year propensity matched cohort analysis.1 passage
• Increased rebleeding and mortality in patients with gastrointestinal bleeding treated with anticoagulant drugs compared to antiplatelet drugs.1 passage
• Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.1 passage
• Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection.1 passage
• Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores.1 passage
• Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.1 passage
• Industry funding effect on positive results of probiotic use in the management of acute diarrhea: a systematized review.1 passage
• Infected retroperitoneal pelvic necrosis in severe acute pancreatitis: how can we manage it?1 passage
• Infection as a predictor of mortality in decompensated liver cirrhosis: exploring the relationship to severity of liver failure.1 passage
• Infectious endocarditis in the case of cirrhosis: where do we stand?1 passage
• Inflammation-based prognostic scores predict disease severity in patients with acute cholecystitis.1 passage
• Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI.1 passage
• Inflammatory bowel disease among Bedouin Arabs in southern Israel: urbanization and increasing prevalence rates.1 passage
• Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?1 passage
• Inflammatory bowel disease versus Chlamydia trachomatis infection: a case report and revision of the literature.1 passage
• Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.1 passage
• Infliximab for the treatment of Crohn's disease: efficacy and safety in a Chinese single-center retrospective study.1 passage
• Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab.1 passage
• Influence factors and a predictive scoring model for measuring the biochemical response of primary biliary cholangitis to ursodeoxycholic acid treatment.1 passage
• Influence of diabetes mellitus on energy metabolism in patients with alcoholic liver cirrhosis.1 passage
• Influence of esophageal variceal bleeding on iron status in chronic hepatitis C patients.1 passage
• Influence of female sex on hepatitis C virus infection progression and treatment outcomes.1 passage
• Influence of genetic variations in the SOD1 gene on the development of ascites and spontaneous bacterial peritonitis in decompensated liver cirrhosis.1 passage
• Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17.1 passage
• Influence of periampullary diverticulum on the occurrence of pancreaticobiliary diseases and outcomes of endoscopic retrograde cholangiopancreatography.1 passage
• Influence of preoperative sodium concentration on outcome of patients with hepatitis B virus cirrhosis after liver transplantation.1 passage
• Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.1 passage
• Innovative percutaneous antegrade clearance of intrahepatic and extrahepatic biliary stones with the use of a hysterosalpingography catheter.1 passage
• Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment.1 passage
• Insulin resistance is associated with elevated transaminases and low aspartate aminotransferase/alanine aminotransferase ratio in young adults with normal weight.1 passage
• Insulin resistance is associated with esophageal varices in alcoholic liver disease patients.1 passage
• Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma.1 passage
• Integrated medical-psychiatric outpatient care in functional gastrointestinal disorders improves outcome: a pilot study.1 passage
• Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.1 passage
• Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.1 passage
• Interrater reliability of the assessment of disease activity by gastrointestinal ultrasound in a prospective cohort of patients with inflammatory bowel disease.1 passage
• Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience.1 passage
• Intestinal failure in Finland: prevalence and characteristics of an adult patient population.1 passage
• Intrahepatic biliary strictures after liver transplantation are morphologically similar to primary sclerosing cholangitis but immunologically distinct.1 passage
• Intrahepatic cholestasis of pregnancy with concomitant hepatitis C virus infection, Joan C. Edwards SOM, Marshall University.1 passage
• Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma.1 passage
• Intraoperative systemic biomarkers predict post-liver transplantation acute kidney injury.1 passage
• Intravenous iron versus oral iron or observation for gastrointestinal malignancies: a systematic review.1 passage
• Invasive management of symptomatic hepatic hemangioma.1 passage
• Investigation of liver dysfunction: who should we test for hepatitis E?1 passage
• Investing in workability of patients with inflammatory bowel disease: results of a pilot project Activ84worK (Activate for work).1 passage
• Iron deficiency anemia in gastric cancer: a Canadian retrospective review.1 passage
• Is Doppler/Dopplex ultrasonography reliable in the assessment of percutaneous ablative therapies of hepatocellular carcinoma: a prospective cross-sectional study.1 passage
• Is coffee ground vomiting important? Findings from a large bleeding unit database and outcomes at 30 days.1 passage
• Is endoscopic sphincterotomy beneficial for the treatment of acute gallstone pancreatitis with small bile duct stone?1 passage
• Is ileocecal valve intubation essential for routine colonoscopic examination?1 passage
• Is insertion of a plastic stent better and safer than epinephrine injection in post sphincterotomy bleeding?1 passage
• Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation?1 passage
• Is there a relationship between gluten sensitivity and postural tachycardia syndrome?1 passage
• Is there an association between peptic ulcer disease and osteoporosis: a systematic review and cumulative analysis.1 passage
• Is there any role of renin-angiotensin system inhibitors in modulating inflammatory bowel disease outcome?1 passage
• Is urinary β2-microglobulin a reliable marker for assessment of renal tubular dysfunction in chronic hepatitis B patients receiving tenofovir therapy?1 passage
• Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes.1 passage
• Isolated ileal blind loop inflammation after intestinal resection with ileocolonic anastomosis in Crohn's disease: an often neglected endoscopic finding with an unfavorable outcome.1 passage
• JINLING (Judicious INdex of Luminal INflammation Grade) score, an effective indicator to assess inflammation severity in Crohn's disease.1 passage
• Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma.1 passage
• Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumors.1 passage
• Kinetic patterns of liver enzyme elevation with COVID-19 in the USA.1 passage
• King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.1 passage
• Knowledge of 5-aminosalicylic acid nephrotoxicity and adherence to kidney function monitoring of patients with inflammatory bowel disease.1 passage
• L-carnitine reduces hospital admissions in patients with hepatic encephalopathy.1 passage
• LI-RADS: a great opportunity not to be missed.1 passage
• Labour productivity losses caused by premature death associated with hepatitis C in Spain.1 passage
• Lack of anti-TNF drugs levels in fistula tissue - a reason for nonresponse in Crohn's perianal fistulating disease?1 passage
• Lactate serum concentrations during treatment with nucleos(t)ide analogues in hepatitis B with or without cirrhosis.1 passage
• Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.1 passage
• Landmarks for dual biological therapy in inflammatory bowel disease: lesson from two case reports of vedolizumab in combination with ustekinumab.1 passage
• Laparoscopic-assisted colorectal surgery benefits visceral obesity patients: a propensity-matched analysis.1 passage
• Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study.1 passage
• Length of endoscopic workup in gastrointestinal bleeding.1 passage
• Leucine-rich alpha-2 glycoprotein 1, high mobility group box 1, matrix metalloproteinase 3 and annexin A1 as biomarkers of ulcerative colitis endoscopic and histological activity.1 passage
• Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis.1 passage
• Limitations of teaching endoscopy.1 passage
• Linkage to care of HbsAg-positive and anti-HCV-positive patients after a systematic screening approach in the German primary care setting.1 passage
• Literature review: impacts of socioeconomic status on the risk of inflammatory bowel disease and its outcomes.1 passage
• Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature.1 passage
• Liver cirrhosis affects serum lactate level measurement while assessing disease severity in patients with sepsis.1 passage
• Liver fibrosis regression correlates with downregulation in liver angiogenesis in chronic hepatitis C through viral eradication.1 passage
• Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis.1 passage
• Liver steatosis is a risk factor for hepatotoxicity in inflammatory bowel disease patients treated with azathioprine.1 passage
• Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.1 passage
• Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort.1 passage
• Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.1 passage
• Liver stiffness measurement by acoustic radiation forced impulse and transient elastography in patients with intrahepatic cholestasis.1 passage
• Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.1 passage
• Liver stiffness measurement is a potent predictor of histological fibrosis regression after hepatitis C virus clearance.1 passage
• Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.1 passage
• Long noncoding RNA KIF9-AS1 promotes cell apoptosis by targeting the microRNA-148a-3p/suppressor of cytokine signaling axis in inflammatory bowel disease.1 passage
• Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease.1 passage
• Long-term assessment of clinical response to adalimumab therapy in refractory ulcerative colitis.1 passage
• Long-term clinical outcome of Budd-Chiari syndrome in children after radiological intervention.1 passage
• Long-term clinical outcomes in sustained responders with chronic hepatitis C after treatment with direct-acting antivirals.1 passage
• Long-term cumulative incidence of metachronous advanced colorectal neoplasia after colonoscopy and a novel risk factor: a cohort study.1 passage
• Long-term dynamics of gastric biomarkers after eradication of Helicobacter pylori infection.1 passage
• Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients.1 passage
• Long-term follow-up of HBsAg-positive patients in Germany.1 passage
• Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.1 passage
• Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence.1 passage
• Long-term outcome of neonates with suspected Hirschsprung's disease, but normal rectal biopsy.1 passage
• Long-term outcomes in patients diagnosed with bile-acid diarrhoea.1 passage
• Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer: a systematic review and meta-analysis.1 passage
• Long-term outcomes of individualized interventional treatment for primary Budd-Chiari syndrome complicated by inferior vena cava thrombosis.1 passage
• Long-term outcomes of interventional treatment for Budd-Chiari syndrome with chronic accessory hepatic vein obstruction.1 passage
• Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome.1 passage
• Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model.1 passage
• Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients.1 passage
• Long-term rebleeding risk following endoscopic therapy of small-bowel vascular lesions with device-assisted enteroscopy.1 passage
• Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome.1 passage
• Long-term survival prediction for transjugular intrahepatic portosystemic shunt in severe cirrhotic ascites: assessment of ten prognostic models.1 passage
• Longer duration of transient elastography predicts unreliable liver stiffness measurements.1 passage
• Low dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy.1 passage
• Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease.1 passage
• Low myocardial mechano-energetic efficiency is an independent predictor of prognosis in advanced chronic liver disease.1 passage
• Low potency of fecal immunological surveillance testing soon after negative colonoscopy or resection of low-risk adenoma in average-risk patients.1 passage
• Low prevalence of upper endoscopic gastrointestinal findings despite high frequency of alarm symptoms at the time of diagnosis in adult coeliac disease.1 passage
• Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system.1 passage
• Low-free triiodothyronine is associated with poor prognosis of portal hypertension in cirrhosis.1 passage
• Lumen-apposing metal stents in interventional endoscopy: a state-of-the-art review with focus on technical and clinical successes and complications.1 passage
• Lymph node metastasis can be determined by just tumor depth and lymphovascular invasion in early gastric cancer patients after endoscopic submucosal dissection.1 passage
• Lymphocyte-monocyte ratio at admission predicts possible outcomes in patients with acute-on-chronic liver failure.1 passage
• MDCT classification of steatotic liver: a multicentric analysis.1 passage
• MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt.1 passage
• MRI assessed pancreatic morphology and exocrine function are associated with disease burden in chronic pancreatitis.1 passage
• MRI characteristics for the differential diagnosis of benign and malignant small solitary hypovascular hepatic nodules.1 passage
• MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease.1 passage
• MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer.1 passage
• Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids.1 passage
• Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.1 passage
• Magnifying endoscopy with narrow-band image for diagnosing diffuse type of gastric antral vascular ectasia in cirrhotic patients.1 passage
• Maintenance therapy for Crohn's disease: should it be indefinite?1 passage
• Major changes in the number and indications of liver biopsy for chronic liver diseases over one decade in France.1 passage
• Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.1 passage
• Male hepatitis C patients' sexual functioning and its determinants.1 passage
• Malnutrition and sarcopenia are prevalent among inflammatory bowel disease patients with clinical remission.1 passage
• Management and outcomes of hepatorenal syndrome at an urban academic medical center: a retrospective study.1 passage
• Management of coeliac disease patients after the confirmation of diagnosis in Central Europe.1 passage
• Management of different types of gastric varices with band ligation: a 3-year experience.1 passage
• Management of gastric varices: a French national survey.1 passage
• Management of portal vein thrombosis in cirrhosis: an update.1 passage
• Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium.1 passage
• Management of type II endoscopic retrograde cholangiopancreatography-related perforations by placement of multiple plastic stents.1 passage
• Mansoura simple scoring system for prediction of spontaneous bacterial peritonitis: lesson learnt.1 passage
• Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associations.1 passage
• Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis.1 passage
• Markers of gastric intestinal metaplasia under digital chromoendoscopy: systematic review and meta-analysis.1 passage
• Mean platelet volume and platelet to lymphocyte count ratio are associated with hepatitis B-related liver fibrosis.1 passage
• Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C.1 passage
• Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.1 passage
• Measuring gaze patterns during colonoscopy: a useful tool to evaluate colon inspection?1 passage
• Measuring the value of endoscopic retrograde cholangiopancreatography activity: an opportunity to stratify endoscopists on the basis of their value.1 passage
• Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.1 passage
• Meta-analysis indicates that add-on devices and new endoscopes reduce colonoscopy adenoma miss rate.1 passage
• Microcirculatory changes in the liver of patients with refractory ascites and their relationship with diabetes and alcohol.1 passage
• Micronutrient deficits in patients with chronic pancreatitis: prevalence, risk factors and pitfalls.1 passage
• Midodrine and albumin versus albumin alone for the secondary prophylaxis of acute kidney injury in a patient with cirrhosis and ascites.1 passage
• Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis.1 passage
• Mixed histology poses a greater risk for noncurative endoscopic resection in early gastric cancers regardless of the predominant histologic types.1 passage
• Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.1 passage
• Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.1 passage
• Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy.1 passage
• Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.1 passage
• Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.1 passage
• Morbidity and mortality during hepatitis C treatment using sofosbuvir and daclatasvir with or without ribavirin, in a cohort of Egyptian patients.1 passage
• Morning versus afternoon adenoma detection rate: a systematic review and meta-analysis.1 passage
• Mucin gene expression in the intestine of ulcerative colitis patients: a systematic review and meta-analysis.1 passage
• Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort.1 passage
• Multidetector computed tomography chest findings of coronavirus disease 2019 pneumonia in patient with hepatocellular carcinoma.1 passage
• Multiple biopsy passes and the risk of complications of percutaneous liver biopsy.1 passage
• Multiplication product of Model for End-stage Liver Disease and Donor Risk Index as predictive models of survival after liver transplantation.1 passage
• Muscle deficits with normal bone microarchitecture and geometry in young adults with well-controlled childhood-onset Crohn's disease.1 passage
• Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease.1 passage
• NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.1 passage
• NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease.1 passage
• Narrow band imaging characteristics of gastric polypoid lesions: a single-center prospective pilot study.1 passage
• Nationwide large survey on hepatitis B surface antigen quantification use in real-life clinical practice.1 passage
• Natural history and predictors associated with the evolution of portal venous system thrombosis in liver cirrhosis.1 passage
• Needle-based confocal laser endomicroscopy in pancreatic cysts: a meta-analysis.1 passage
• Neutrophil-lymphocyte ratio and the risk of hepatocellular carcinoma in patients with hepatitis B-caused cirrhosis.1 passage
• Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma.1 passage
• Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease.1 passage
• Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.1 passage
• New and emerging therapies in treatment of Clostridium difficile infection.1 passage
• New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.1 passage
• No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk.1 passage
• No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.1 passage
• No evidence of "weekend effect" in upper gastrointestinal bleeding in Italy: data from a nationwide prospective registry.1 passage
• No reduction of radiation dose following the introduction of dose-area product measurement in endoscopic retrograde cholangiopancreatography.1 passage
• Nomogram for predicting diabetes mellitus after the first attack of acute pancreatitis.1 passage
• Nomogram for predicting the risk of gastroesophageal varices after primary endoscopic prophylaxis for variceal hemorrhage in patients with cirrhosis.1 passage
• Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?1 passage
• Non-alcoholic fatty liver disease in inflammatory bowel disease patients.1 passage
• Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis.1 passage
• Nonalcoholic fatty liver disease and alteration in semen quality and reproductive hormones.1 passage
• Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis.1 passage
• Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis.1 passage
• Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.1 passage
• Nonalcoholic fatty liver disease can be predicted by retinal vascular changes in patients with obesity without hypertension or diabetes.1 passage
• Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study.1 passage
• Nonalcoholic fatty liver disease is associated with a higher incidence of coeliac disease.1 passage
• Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic form: definitive evidence from meta-analysis and trial sequential analysis.1 passage
• Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic area.1 passage
• Nonalcoholic fatty liver disease-related cardiovascular risk: Is there an association with blood hemoglobin levels?1 passage
• Nonalcoholic fatty liver disease: a potential consequence of tumor necrosis factor-inhibitor therapy.1 passage
• Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina.1 passage
• Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies.1 passage
• Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals.1 passage
• Nonalcoholic fatty pancreas disease is related independently to the severity of acute pancreatitis.1 passage
• Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.1 passage
• Noncompliance with guidelines on proton pump inhibitor prescription as gastroprotection in hospitalized surgical patients who are prescribed NSAIDs.1 passage
• Noninvasive assessment of liver fibrosis in Crohn's disease patients exposed to methotrexate.1 passage
• Noninvasive assessment of liver fibrosis in a real-world cohort of patients with known or suspected chronic liver disease using 2D-shear wave elastography.1 passage
• Noninvasive assessment of liver stiffness by transient elastography (FibroScan) in liver fluke disease.1 passage
• Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test.1 passage
• Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link.1 passage
• Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.1 passage
• Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients.1 passage
• Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.1 passage
• Norfloxacin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifaximin for the prevention of spontaneous bacterial peritonitis: a network meta-analysis.1 passage
• Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.1 passage
• Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis.1 passage
• Novel predictors for liver transplantation or death in drug-induced acute liver failure.1 passage
• Novel therapies and potential therapeutic targets in the management of chronic hepatitis B.1 passage
• Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.1 passage
• Obstructive colon cancers at endoscopy are associated with advanced tumor stage and poor patient outcome. A retrospective study on 398 patients.1 passage
• Obstructive sleep apnea and severity of nonalcoholic fatty liver disease.1 passage
• Obstructive sleep apnea is associated with fatty liver index, the index of nonalcoholic fatty liver disease.1 passage
• Occult hepatitis B and HIV infection.1 passage
• Occult hepatitis B infection in children with chronic liver disease.1 passage
• Occurrence and clinical characteristics of occult hepatitis C virus infection in hemodialysis units at Ismailia, Egypt.1 passage
• Occurrence and predictors of metaplastic atrophic gastritis in a nation-wide consecutive endoscopic population presenting with upper gastrointestinal symptoms.1 passage
• Ocular radiation exposure during endoscopic retrograde cholangiopancreatography: a meta-analysis of studies.1 passage
• Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV).1 passage
• On-treatment and off-treatment efficacy of entecavir in a real-life cohort of chronic hepatitis B patients.1 passage
• One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.1 passage
• Only one-third of hepatocellular carcinoma cases are diagnosed via screening or surveillance: a systematic review and meta-analysis.1 passage
• Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI.1 passage
• Optical effect of spraying l-menthol on gastric intestinal metaplasia visualized by linked color imaging.1 passage
• Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study.1 passage
• Optimal management of functional anorectal pain: a systematic review and network meta-analysis.1 passage
• Optimal thresholds for ultrasound attenuation parameter in the evaluation of hepatic steatosis severity: evidence from a cohort of patients with biopsy-proven fatty liver disease.1 passage
• Optimized thiopurine therapy before withdrawal of anti-tumour necrosis factor-α in patients with Crohn's disease.1 passage
• Optimizing the performance of magnetic-assisted capsule endoscopy of the upper GI tract using multiplanar CT modelling.1 passage
• Oral health in patients with liver cirrhosis.1 passage
• Oral manifestations of inflammatory bowel disease: the neglected piece of the puzzle.1 passage
• Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.1 passage
• Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.1 passage
• Organ dysfunction in cirrhosis: a mechanism involving the microcirculation.1 passage
• Orphenadrine in treatment of muscle cramps in cirrhotic patients: a randomized study.1 passage
• Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: a case series from a transplant center.1 passage
• Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study.1 passage
• Outcome of the Z-expandable metallic stent for Budd-Chiari syndrome and segmental obstruction of the inferior vena cava.1 passage
• Outcomes and costs of treating hepatitis C patients with second-generation direct-acting antivirals: results from the German Hepatitis C-Registry.1 passage
• Outcomes of initial medical compared with surgical strategies in the management of intra-abdominal abscesses in patients with Crohn's disease: a meta-analysis.1 passage
• Outcomes of patients hospitalized with peptic ulcer disease diagnosed in acute upper endoscopy.1 passage
• Outcomes of sorafenib therapy in advanced hepatocellular carcinoma in a single center in Ethiopia.1 passage
• Outpatient management of low-risk patients with upper gastrointestinal bleeding: can we safely extend the Glasgow Blatchford Score in clinical practice?1 passage
• Outpatient treatment of uncomplicated diverticulitis: a systematic review.1 passage
• Overlooked muscle cramps in patients with chronic liver disease: in relation to the prevalence of muscle cramps.1 passage
• Overview in the clinical management of patients with seronegative villous atrophy.1 passage
• P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control study.1 passage
• PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs.1 passage
• PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks.1 passage
• Paediatric gastrointestinal endoscopy: a qualitative study.1 passage
• Paediatric inflammatory bowel disease in India: a prospective multicentre study.1 passage
• Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome?1 passage
• Pancreatic and hepatobiliary manifestations of nonalcoholic fatty pancreatic disease: a referral multi-center experience.1 passage
• Pancreaticoduodenectomy for nonampullary duodenal lesions: indications and results.1 passage
• Pancreatobiliary manifestations of nonalcoholic fatty liver disease: a retrospective case-control multicenter study.1 passage
• Panintestinal capsule endoscopy in patients with celiac disease.1 passage
• Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.1 passage
• Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature.1 passage
• Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.1 passage
• Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?1 passage
• Patient education and its effect on self-management in cirrhosis: a pilot study.1 passage
• Patient tolerance and acceptance of different colonic imaging modalities: an observational cohort study.1 passage
• Patient's perspective on the implementation of measures to contain the SARS-CoV-2 pandemic in a Portuguese Gastroenterology Department.1 passage
• Patient-reported experience measure in pancreatobiliary endoscopy: a systematic review to highlight areas for improvement.1 passage
• Patients developing inflammatory bowel disease have iron deficiency and lower plasma ferritin years before diagnosis: a nested case-control study.1 passage
• Patients with suboptimal hepatitis B virus diagnostic characterization are at risk of liver fibrosis progression.1 passage
• Patients' beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases.1 passage
• Patients' perspectives on medication for inflammatory bowel disease: a mixed-method systematic review.1 passage
• Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?1 passage
• Patterns of splenic arterial enhancement on computed tomography are related to changes in portal venous pressure.1 passage
• Patterns of splenic arterial enhancement on computed tomography scan are related to portal venous hypertension.1 passage
• Perceived stress as a risk factor for dyspepsia: a register-based cohort study.1 passage
• Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey.1 passage
• Percutaneous endoscopic gastrostomy under conscious sedation in patients with amyotrophic lateral sclerosis is safe: an observational study.1 passage
• Percutaneous endoscopic gastrostomy with and without jejunal extension in patients with amyotrophic lateral sclerosis.1 passage
• Percutaneous endoscopic gastrostomy: confirming the clinical benefits far beyond anthropometry.1 passage
• Performance and cutoffs for liver fibrosis staging of a two-dimensional shear wave elastography technique.1 passage
• Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.1 passage
• Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation.1 passage
• Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.1 passage
• Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes.1 passage
• Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease.1 passage
• Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.1 passage
• Perioperative blood transfusion and the clinical outcomes of patients undergoing cholangiocarcinoma surgery: a systematic review and meta-analysis.1 passage
• Perioperative prophylaxis with single-dose cefazolin for liver transplantation: a retrospective study.1 passage
• Peripheral monocyte counts predict the clinical outcome for patients with colorectal cancer: a systematic review and meta-analysis.1 passage
• Peroral ceroral endoscopic myotomy treatment for symptomatic esophageal diverticulum: a systematic review and meta-analysis.1 passage
• Peroral cholangioscopy with cholangioscopy-directed biopsies in the diagnosis of biliary malignancies: a systemic review and meta-analysis.1 passage
• Peroral endoscopic full-thickness myotomy for the treatment of sigmoid-type achalasia: outcomes with a minimum follow-up of 12 months.1 passage
• Peroral endoscopic myotomy versus pneumatic dilation for achalasia: a systematic review and meta-analysis.1 passage
• Persistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort study.1 passage
• Persisting changes of intestinal microbiota after bowel lavage and colonoscopy.1 passage
• Personalized treatment approach to gastroenteropancreatic neuroendocrine tumors: a medical oncologist's perspective.1 passage
• Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.1 passage
• Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysis.1 passage
• Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease.1 passage
• Pocket-creation method improves efficacy of colorectal endoscopic submucosal dissection: a system review and meta-analysis.1 passage
• Polyethylene glycol combined with linaclotide is an effective and well-tolerated bowel preparation regimen for colonoscopy: an endoscopist-blinded, randomized, controlled trial.1 passage
• Polymorphisms in Toll-like receptors 1, 2, 5, and 10 are associated with predisposition to Helicobacter pylori infection.1 passage
• Polyp detection rate may predict adenoma detection rate: a meta-analysis.1 passage
• Population-based incidence and prevalence of inflammatory bowel diseases in Milan (Northern Italy), and estimates for Italy.1 passage
• Portal decompression with transjugular intrahepatic portosystemic shunt prior to nonhepatic surgery: a single-center case series.1 passage
• Portal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates.1 passage
• Portal hypertensive gastropathy in cirrhotics without varices: a case-control study.1 passage
• Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort.1 passage
• Post-colonoscopy colorectal cancers in Sweden: room for quality improvement.1 passage
• Postcholecystectomy biliary injuries: frequency, and role of early versus late endoscopic retrograde cholangiopancreatography.1 passage
• Postoperative outcomes following inguinal hernia repair in inflammatory bowel disease patients compared to matched controls.1 passage
• Practices, attitudes, and knowledge about Crohn's disease and smoking cessation among gastroenterologists.1 passage
• Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19.1 passage
• Precursors of pancreatic cancer.1 passage
• Predictability of capsule endoscopy referred to a tertiary care center for double-balloon enteroscopy.1 passage
• Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers.1 passage
• Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.1 passage
• Predicting survival time of Korean hepatocellular carcinoma patients using the Cox proportional hazards model: a retrospective study based on big data analysis.1 passage
• Prediction factors of tolvaptan effectiveness in patients with refractory ascites complicated with hepatocellular carcinoma.1 passage
• Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir.1 passage
• Prediction of high-risk esophageal varices in patients with compensated cirrhosis using albumin-bilirubin-platelet score.1 passage
• Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.1 passage
• Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib.1 passage
• Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis.1 passage
• Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease.1 passage
• Predictive value of noninvasive indices in chronic hepatitis B virus-related fibrosis.1 passage
• Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates.1 passage
• Predictors for the progression of hepatic cirrhosis to hepatocellular carcinoma under long-term antiviral therapy.1 passage
• Predictors of bile tree pathology in patients presenting with gallbladder disease.1 passage
• Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: results of a real-life cohort.1 passage
• Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation.1 passage
• Predictors of fecal transplant failure.1 passage
• Predictors of inadequate bowel preparation for colonoscopy: a systematic review and meta-analysis.1 passage
• Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn's disease treated with antitumor necrosis factor-alpha agents based on Parks' classification.1 passage
• Predictors of pouchitis after ileal pouch-anal anastomosis in pediatric-onset ulcerative colitis.1 passage
• Preexisting opioid use disorder is associated with poor outcomes in hospitalized acute pancreatitis patients.1 passage
• Preliminary examination of the relations between disease stage, illness perceptions, coping strategies, and psychological morbidity in chronic hepatitis B and C guided by the Common-Sense Model of Illness.1 passage
• Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatment.1 passage
• Prevalence and characteristics of hepatopulmonary syndrome in children with cirrhosis in southern Brazil.1 passage
• Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.1 passage
• Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases.1 passage
• Prevalence and epidemiology of hepatitis D among patients with chronic hepatitis B virus infection: a report from Northern Spain.1 passage
• Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.1 passage
• Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.1 passage
• Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients: a multicentric study.1 passage
• Prevalence of Barrett's esophagus in a Southern European country: a multicenter study.1 passage
• Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.1 passage
• Prevalence of dyspepsia in patients with cholecystolithiasis: a systematic review and meta-analysis.1 passage
• Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter.1 passage
• Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.1 passage
• Prevalence of hepatitis B and hepatitis C infection from a population-based study in Southern India.1 passage
• Prevalence of inflammatory bowel disease in young Greek Army male recruits from 2006 to 2018: a 13-year retrospective study from a tertiary center.1 passage
• Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients.1 passage
• Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection.1 passage
• Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.1 passage
• Prevalence, incidence and clinical features of SARS-CoV-2 infection in adult coeliac patients.1 passage
• Prevalence, incidence, and autoimmune comorbidities of celiac disease: a nation-wide, population-based study in Denmark from 1977 to 2016.1 passage
• Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment.1 passage
• Primary biliary cholangitis is more severe in previous hepatitis B virus infection patients.1 passage
• Primary presentation of COVID-19 solely with gastrointestinal symptoms: a problem for the containment of the disease.1 passage
• Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.1 passage
• Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.1 passage
• Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.1 passage
• Proactive therapeutic drug monitoring is more effective than conventional management in inducing fecal calprotectin remission in inflammatory bowel disease.1 passage
• Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis.1 passage
• Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis.1 passage
• Profiling for primary-care presentation, investigation and referral for liver cancers: evidence from a national audit.1 passage
• Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience.1 passage
• Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter study.1 passage
• Prognosis of patients with gastric variceal bleeding after endoscopic variceal obturation according to the type of varices.1 passage
• Prognosis of synchronous colorectal carcinoma compared to solitary colorectal carcinoma: a matched pair analysis.1 passage
• Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study.1 passage
• Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.1 passage
• Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis.1 passage
• Prognostic significance of inflammation-based score in patients with hepatocellular carcinoma after liver transplantation.1 passage
• Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.1 passage
• Prognostic value of international normalized ratio to albumin ratio among critically ill patients with cirrhosis.1 passage
• Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt.1 passage
• Prognostic value of telomere function in gastric cancers with and without microsatellite instability.1 passage
• Prophylactic efficacy of a novel method against postendoscopic papillary balloon dilation pancreatitis.1 passage
• Propofol alone prevents worsening hepatic encephalopathy rather than midazolam alone or combined sedation after esophagogastroduodenoscopy in compensated or decompensated cirrhotic patients.1 passage
• Propranolol associated with endoscopic band ligation reduces recurrence of esophageal varices for primary prophylaxis of variceal bleeding: a randomized-controlled trial.1 passage
• Prospective evaluation of the performance and interobserver variation in endoscopic ultrasound staging of rectal cancer.1 passage
• Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women.1 passage
• Prospective multicenter validation of the Glasgow Blatchford bleeding score in the management of patients with upper gastrointestinal hemorrhage presenting at an emergency department.1 passage
• Protein misfolding in combination with other risk factors in CEL-HYB1-mediated chronic pancreatitis.1 passage
• Protocol liver biopsies in stable long-term pediatric liver transplant recipients: risk or benefit?1 passage
• Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.1 passage
• Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma.1 passage
• Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis.1 passage
• Proton-pump-inhibitor use associated with lower short-term rebleeding and mortality in patients receiving esophageal variceal band ligation: a retrospective cohort study.1 passage
• Psychological defense mechanisms and use of corporeal discourse: a comparison between patients with irritable bowel syndrome, medical personnel and healthy volunteers.1 passage
• Psychological interventions for reducing anxiety in patients undergoing first-time colonoscopy: a pilot and feasibility study.1 passage
• Pulmonary functions in children with inflammatory bowel disease.1 passage
• Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.1 passage
• Pyostomatitis vegetans in a pediatric patient with ulcerative colitis: case report of a rare pediatric inflammatory bowel disease extraintestinal manifestation and review of the literature.1 passage
• Qualitative sonographic assessment of transmural ileal inflammation in Crohn's disease: a comparison with MRI activity score.1 passage
• Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-α.1 passage
• Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients.1 passage
• Quality of life related to oral, subcutaneous, and intravenous biologic treatment of inflammatory bowel disease: a time trade-off study.1 passage
• Quick chronic liver failure-sequential organ failure assessment: an easy-to-use scoring model for predicting mortality risk in critically ill cirrhosis patients.1 passage
• Radioembolization-induced liver disease: a systematic review.1 passage
• Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.1 passage
• Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.1 passage
• Randomized clinical trial: efficacy of a food supplement, TRANSITECH, on healthy individuals with mild intermittent constipation.1 passage
• Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy.1 passage
• Randomized controlled trial comparing endoscopic ligation with or without sclerotherapy for secondary prophylaxis of variceal bleeding.1 passage
• Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy.1 passage
• Randomized placebo-controlled study of baclofen in the treatment of muscle cramps in patients with liver cirrhosis.1 passage
• Randomized-controlled trial of methocarbamol as a novel treatment for muscle cramps in cirrhotic patients.1 passage
• Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.1 passage
• Rate of employment after liver transplantation in France: a single-centre study.1 passage
• Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.1 passage
• Ratio of platelet count/spleen diameter predicted the presence of esophageal varices in patients with schistosomiasis liver cirrhosis.1 passage
• Re-induction with intravenous Ustekinumab after secondary loss of response is a valid optimization strategy in Crohn's disease.1 passage
• Re: Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter? (Eur J Gastroenterol Hepatol 2015, 27:1063-1068).1 passage
• Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab.1 passage
• Real-world clinical and endoscopic outcomes after one year tofacitinib treatment in ulcerative colitis.1 passage
• Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders.1 passage
• Reappraisal of upper age limit for adult living-donor liver transplantation using right lobe grafts: an outcome analysis.1 passage
• Reasons why the diagnosis of serrated polyposis syndrome is missed.1 passage
• Rebleeding after hemoclip versus argon plasma coagulation for gastrointestinal angiodysplasias: a retrospective multicenter study.1 passage
• Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations.1 passage
• Recurrence of spontaneous bacterial peritonitis in cirrhosis: novel predictors.1 passage
• Recurrence rate and overall survival of operated ruptured hepatocellular carcinomas.1 passage
• Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients.1 passage
• Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients.1 passage
• Red blood cell distribution width for predicting significant liver inflammation in patients with autoimmune hepatitis.1 passage
• Red blood cell distribution width independently predicts 1-month mortality in acute decompensation of cirrhotic patients admitted to emergency department.1 passage
• Red blood cell distribution width: a potential prognostic index for short-term mortality of patients admitted to emergency department for acute decompensation of liver cirrhosis?1 passage
• Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk.1 passage
• Reducing prophylactic antibiotics use in laparoscopic cholecystectomy and liver resections.1 passage
• Reduction in postpercutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis.1 passage
• Refeeding syndrome in the gastroenterology practice: how concerned should we be?1 passage
• Regarding the 'Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma'.1 passage
• Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.1 passage
• Regression tree for choledocholithiasis prediction.1 passage
• Reinvitation to screening colonoscopy: a randomized-controlled trial of reminding letter and invitation to educational meeting on attendance in nonresponders to initial invitation to screening colonoscopy (REINVITE).1 passage
• Relationship between atrophic gastritis, serum ghrelin and body mass index.1 passage
• Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis.1 passage
• Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study.1 passage
• Relationship of hepatic fibrosis, cirrhosis, and mortality with cholecystectomy in patients with hepatitis C virus infection.1 passage
• Reliability and applicability of two-dimensional shear-wave elastography for the evaluation of liver stiffness.1 passage
• Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.1 passage
• Reply to the letter to the Editor: 'The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease'.1 passage
• Request of laboratory liver tests in primary care in Spain: potential savings if appropriateness indicator targets were achieved.1 passage
• Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction.1 passage
• Response to: Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin: hepatic encephalopathy in association with zolpidem.1 passage
• Results of a second examination of the right side of the colon in screening and surveillance colonoscopy: a systematic review and meta-analysis.1 passage
• Reticuloendothelial activation correlates with disease severity and predicts mortality in severe alcoholic hepatitis.1 passage
• Retreatment of chronic hepatitis C virus genotype-4 patients after non-structural protein 5A inhibitors' failure: efficacy and safety of different regimens.1 passage
• Retrieval and re-evaluation of previously diagnosed chronic hepatitis C infections lost to medical follow-up in the Netherlands.1 passage
• Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology?1 passage
• Retrospective analysis of children with α-1 antitrypsin deficiency.1 passage
• Review article: safety of new biologic agents for inflammatory bowel disease in the liver.1 passage
• Review of imaging techniques in the diagnosis of hepatocellular carcinoma in patients who require a liver transplant.1 passage
• Rifaximin and midodrine improve clinical outcome in refractory ascites including renal function, weight loss, and short-term survival.1 passage
• Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis.1 passage
• Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot.1 passage
• Risk factors and characteristics associated with nonalcoholic fatty liver disease in patients with ischemic colitis.1 passage
• Risk factors and clinical characteristics of early-onset colorectal cancer vs. late-onset colorectal cancer: a case-case study.1 passage
• Risk factors and prognostic analysis of acute-on-chronic liver failure of chronic hepatitis B after cessation of nucleos(t)ide analogs.1 passage
• Risk factors associated with complications in cirrhotic patients undergoing endoscopic retrograde cholangio-pancreatography.1 passage
• Risk factors associated with refractoriness to esophageal dilatation for benign dysphagia.1 passage
• Risk factors for adverse events of colorectal endoscopic submucosal dissection: a systematic review and meta-analysis.1 passage
• Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease.1 passage
• Risk factors for band-induced ulcer bleeding after prophylactic and therapeutic endoscopic variceal band ligation.1 passage
• Risk factors for bleeding evaluated using the Forrest classification in Japanese patients after endoscopic submucosal dissection for early gastric neoplasm.1 passage
• Risk factors for endoscopic severity of diverticular disease of the colon and its outcome: a real-life case-control study.1 passage
• Risk factors for first-year hospital readmission after liver transplantation.1 passage
• Risk factors for incidentally detected and symptomatic angiodysplasias: a case-control study with the general population as reference.1 passage
• Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.1 passage
• Risk factors for perforation of gastric endoscopic submucosal dissection: a systematic review and meta-analysis.1 passage
• Risk factors for resistance development against lamivudine during long-term treatment of chronic hepatitis B virus infections.1 passage
• Risk factors for the concomitant occurrence of alcoholic chronic pancreatitis and alcoholic liver cirrhosis: a 10-years cohort study at a tertiary hospital in China.1 passage
• Risk of cerebrovascular accident in patients with primary biliary cirrhosis: a systematic review and meta-analysis.1 passage
• Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study.1 passage
• Risk of liver fibrosis progression in patients with suboptimal diagnosis of hepatitis C virus infection.1 passage
• Risk of mortality and level of serum alanine aminotransferase among community-dwelling elderly in Israel.1 passage
• Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study.1 passage
• Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.1 passage
• Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases.1 passage
• Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.1 passage
• Role of cannabis in digestive disorders.1 passage
• Role of endoscopy after an acute episode of diverticulitis: analysis of a cohort of Portuguese patients from a tertiary referral center.1 passage
• Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients.1 passage
• Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma.1 passage
• Role of noninvasive tools for prediction of clinically evident portal hypertension in children.1 passage
• Role of real-time shear-wave elastogarphy in differentiating hepatocellular carcinoma from other hepatic focal lesions.1 passage
• Role of targeted biopsy under magnifying endoscopy with narrow band imaging may be not necessary: a prospective diagnostic accuracy study.1 passage
• Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.1 passage
• Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.1 passage
• Safety and efficacy of a minimally invasive cell sampling device ('Cytosponge') in the diagnosis of esophageal pathology: a systematic review.1 passage
• Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review.1 passage
• Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis.1 passage
• Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis.1 passage
• Safety and efficacy of switching from infliximab biosimilar CT-P13 to infliximab biosimilar SB2 in patients with inflammatory bowel disease.1 passage
• Safety and protection in endoscopic services during phase II of COVID-19 pandemic: a national survey.1 passage
• Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: A retrospective study.1 passage
• Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease.1 passage
• Sarcopenia as prognostic factor for survival after orthotopic liver transplantation.1 passage
• Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases.1 passage
• Sarcopenia impairs health-related quality of life in cirrhotic patients.1 passage
• Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.1 passage
• Sarcopenia is associated with longer hospital stay and multiorgan dysfunction in alcoholic hepatitis.1 passage
• Screening esophagus during routine ultrasound: medical and cost benefits.1 passage
• Screening for colorectal cancer: the role of the primary care physician.1 passage
• Screening for latent tuberculosis in patients with inflammatory bowel disease under antitumor necrosis factor: data from a Portuguese center.1 passage
• Screening for liver cancer during transplant waiting list: a multicenter study from South America.1 passage
• Screening of hepatitis C virus infection in adult general population in Spain.1 passage
• Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.1 passage
• Sedation practice and comfort during colonoscopy: lessons learnt from a national screening programme.1 passage
• Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis.1 passage
• Self-expandable metal stent placement for malignant duodenal obstruction distal to the bulb.1 passage
• Self-medication with oral corticosteroids reported by patients with ulcerative colitis: characteristics, reasons and patients' behaviors.1 passage
• Self-reported nonceliac wheat sensitivity in an outpatient digestive endoscopy center: high frequency but insufficient medical approach.1 passage
• Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn's disease in patients started on antitubercular therapy.1 passage
• Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation.1 passage
• Serological screening for celiac disease in a northern Italian child and adolescent population after the onset of type 1 diabetes: a retrospective longitudinal study of a 7-year period.1 passage
• Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.1 passage
• Seroprevalence of hepatitis E virus in Argentinean blood donors.1 passage
• Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.1 passage
• Serum CD64 and ascitic fluid calprotectin and microRNA-155 as potential biomarkers of spontaneous bacterial peritonitis.1 passage
• Serum alanine aminotransferase levels and all-cause mortality.1 passage
• Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.1 passage
• Serum ammonia as a non-invasive marker for early prediction of esophageal varices.1 passage
• Serum anandamide level as a potential indicator for nonalcoholic fatty liver disease severity.1 passage
• Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology.1 passage
• Serum copper, ceruloplasmin, and their relations to metabolic factors in nonalcoholic fatty liver disease: a cross-sectional study.1 passage
• Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.1 passage
• Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes.1 passage
• Serum fibrosis markers could aid in the prediction of factor for successful oral antiviral treatment in hepatitis C.1 passage
• Serum lactate level accurately predicts mortality in critically ill patients with cirrhosis with acute kidney injury.1 passage
• Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.1 passage
• Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.1 passage
• Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet.1 passage
• Serum visfatin level as a noninvasive marker for nonalcoholic fatty liver disease in children and adolescents with obesity: relation to transient elastography with controlled attenuation parameter.1 passage
• Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis.1 passage
• Serum γ-globulin and albumin concentrations predict secondary loss of response to anti-TNFα in inflammatory bowel disease patients.1 passage
• Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study.1 passage
• Severe pancytopenia and aspergillosis caused by thioguanine in a thiopurine S-methyltransferase deficient patient: a case report.1 passage
• Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality.1 passage
• Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project).1 passage
• Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.1 passage
• Sexual functioning in patients with chronic hepatitis C: a systematic review.1 passage
• Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.1 passage
• Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study.1 passage
• Short article: A randomized-controlled study of sitagliptin for treating diabetes mellitus complicated by nonalcoholic fatty liver disease.1 passage
• Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies.1 passage
• Short article: Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center.1 passage
• Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).1 passage
• Short article: Aspiration of capsule endoscopes: a comprehensive review of the existing literature.1 passage
• Short article: Association between liver fibrosis and hepatitis E seroprevalence among HIV-positive individuals in Nepal.1 passage
• Short article: Buried bumper syndrome in children: incidence and risk factors.1 passage
• Short article: Capsule endoscopy in graft-versus-host disease.1 passage
• Short article: Crohn's disease and pemphigus: is there an association?: a population-based study.1 passage
• Short article: Endoscopic ultrasound-guided fine-needle aspiration of portal vein thrombosis in patients with chronic liver disease and suspicion of hepatocellular carcinoma.1 passage
• Short article: Etiologic profile and endoscopic findings in immunocompromised children and adolescents with gastrointestinal bleeding.1 passage
• Short article: Evaluation of O6-methylguanine-DNA methyltransferase as a predicting factor of response to temozolomide-based chemotherapy in well-differentiated metastatic pancreatic neuroendocrine tumors.1 passage
• Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.1 passage
• Short article: Fatigue in the long term after HCV treatment in HIV-HCV-coinfected patients: functional limitations persist despite viral clearance in patients exposed to peg-interferon/ribavirin-containing regimens (ANRS CO13-HEPAVIH cohort).1 passage
• Short article: Frequency, pathophysiology, and clinical classification of intestinal failure type II and III at a tertiary referral center.1 passage
• Short article: Gastrointestinal bleeding in multiorgan failure.1 passage
• Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.1 passage
• Short article: Hepatitis C and G virus coinfection in Punjab, Pakistan: incidence and its correlation analysis with clinical data.1 passage
• Short article: Hepatitis delta in patients with resolved hepatitis B virus infection.1 passage
• Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions.1 passage
• Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis.1 passage
• Short article: Influence of regulatory NLRC5 variants on colorectal cancer survival and 5-fluorouracil-based chemotherapy.1 passage
• Short article: Management of ruptured hepatocellular carcinoma in a European tertiary care center.1 passage
• Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies.1 passage
• Short article: Negative small-bowel cross-sectional imaging does not exclude capsule retention in high-risk patients.1 passage
• Short article: Noninvasive assessment of portal hypertension and detection of esophageal varices in cirrhosis: state-of-the-art.1 passage
• Short article: Outcome of medical and surgical management for perforated jejunal diverticulitis.1 passage
• Short article: Presence, extent and location of pancreatic necrosis are independent of aetiology in acute pancreatitis.1 passage
• Short article: Recommendations on rectal surveillance for colorectal cancer after subtotal colectomy in patients with inflammatory bowel disease.1 passage
• Short article: Relapsing Whipple's disease: a case report and literature review.1 passage
• Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease.1 passage
• Short article: Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience.1 passage
• Short article: Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.1 passage
• Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases.1 passage
• Short article: Sequence variations of PKHD1 underlie congenital hepatic fibrosis in a Chinese family.1 passage
• Short article: Small intestinal mucosal injury in patients taking chemotherapeutic agents for solid cancers.1 passage
• Short article: Stool cytomegalovirus polymerase chain reaction for the diagnosis of cytomegalovirus-related gastrointestinal disease.1 passage
• Short article: Successful faecal coliform sensitivity-based oral ertapenem therapy for chronic antibiotic-refractory pouchitis: a case series.1 passage
• Short article: Switching to a infliximab biosimilar: short-term results of clinical monitoring in patients with inflammatory bowel disease.1 passage
• Short article: The effect of implementation of a treatment algorithm for infliximab on remission rates and drug costs in inflammatory bowel disease patients.1 passage
• Short article: The endoscopic and histologic findings of infants who have experienced brief resolved unexplained events.1 passage
• Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.1 passage
• Short article: Willingness to undergo colonoscopy with virtual reality instead of procedural sedation and analgesia.1 passage
• Short-term clinical outcomes of non-curative endoscopic submucosal dissection for early esophageal adenocarcinoma.1 passage
• Should we use papilla morphology to estimate the size of the terminal common bile duct during endoscopic retrograde cholangiopancreatography?1 passage
• Sickle cell disease is associated with higher mortality among patients hospitalized with ischemic bowel disease.1 passage
• Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients.1 passage
• Simplified 6-month prediction scores for primary biliary cholangitis patients treated with ursodeoxycholic acid.1 passage
• Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool.1 passage
• Simultaneous local excision of synchronous rectal polyps by transanal endoscopic microsurgery.1 passage
• Single-step endoscopic ultrasound-guided multiple gateway drainage of complex walled-off necrosis with lumen apposing metal stents.1 passage
• Skeletal muscle mass depletion in patients with hepatitis C virus infection.1 passage
• Sleep disruption in nonalcoholic fatty liver disease: What is the role of lifestyle and diet?1 passage
• Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort).1 passage
• Small bowel capsule endoscopy in ulcerative colitis: the capcolitis study: a prospective observational study.1 passage
• Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis.1 passage
• Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease.1 passage
• Small molecule drugs in the treatment of inflammatory bowel diseases: which one, when and why? - a systematic review.1 passage
• Small-bowel mucosal healing assessment by capsule endoscopy as a predictor of long-term clinical remission in patients with Crohn's disease: a systematic review and meta-analysis.1 passage
• Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients.1 passage
• Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study.1 passage
• Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions.1 passage
• Split dose versus full single-dose regimen of polyethylene glycol for bowel preparation in pediatric colonoscopy: a pilot study of randomized controlled trial.1 passage
• Split-dose bowel cleansing with picosulphate is safe and better tolerated than 2-l polyethylene glycol solution.1 passage
• Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.1 passage
• Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis.1 passage
• Spontaneous regression of liver hemangiomas: a single-institution analysis of 46 patients.1 passage
• Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis.1 passage
• Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.1 passage
• Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate.1 passage
• Stress and a sedentary lifestyle are associated with irritable bowel syndrome in medical students from Peru: a cross-sectional study.1 passage
• Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's disease.1 passage
• Study of serology and genetics of celiac disease in patients with juvenile systemic lupus erythematosus 'celiac in juvenile systemic lupus'.1 passage
• Study of the influence of heme oxygenase 1 gene single nucleotide polymorphism (rs2071746) on esophageal varices among patients with cirrhosis.1 passage
• Subclinical spontaneous bacterial peritonitis at the time of liver transplantation does not impact on outcomes.1 passage
• Submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors originating from the muscularis propria layer.1 passage
• Supplementation of ursodeoxycholic acid improves fat digestion and absorption in cystic fibrosis patients with mild liver involvement.1 passage
• Surgery for ulcerative colitis in geriatric patients is safe with similar risk to younger patients.1 passage
• Surgical versus endoscopic resection of large sessile duodenal and papillary lesions.1 passage
• Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis.1 passage
• Survival and recurrence rates of hepatocellular carcinoma after treatment of chronic hepatitis C using direct acting antivirals.1 passage
• Survival and risk factors related to death in outpatients with cirrhosis treated in a clinic in Southern Brazil.1 passage
• Survival outcomes and rate of missed upper gastrointestinal cancers at routine endoscopy: a single centre retrospective cohort study.1 passage
• Switching from branched-chain amino acid granules to branched-chain amino acid-enriched nutrient improves the branched-chain amino acid-to-tyrosine ratio in patients with cirrhosis with hypoalbuminemia: a prospective study.1 passage
• Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results.1 passage
• Symptoms and biomarkers associated with celiac disease: evaluation of a population-based screening program in adults.1 passage
• Symptoms and demographic factors associated with early-onset colorectal neoplasia among individuals undergoing diagnostic colonoscopy.1 passage
• Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity.1 passage
• Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.1 passage
• Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.1 passage
• Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.1 passage
• Systematic review and meta-analysis of dermatological reactions in patients with inflammatory bowel disease treated with anti-tumour necrosis factor therapy.1 passage
• Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis.1 passage
• Systematic review and meta-analysis: monopolar hemostatic forceps with soft coagulation in the treatment of peptic ulcer bleeding.1 passage
• Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients.1 passage
• Systematic review: knowledge and educational needs of patients with irritable bowel syndrome.1 passage
• Systematic review: role of elevated plasma von-Willebrand factor as predictor of mortality in patients with chronic liver disease.1 passage
• Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis.1 passage
• Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices.1 passage
• Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study.1 passage
• Ten years of hospital admissions for liver cirrhosis in Portugal.1 passage
• Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension.1 passage
• Tenofovir and telbivudine combination therapy rapidly decreases viral loads in immune-tolerant chronic hepatitis B patients awaiting assisted reproduction: an open-label, randomized, controlled study.1 passage
• Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy.1 passage
• Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.1 passage
• Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation.1 passage
• The 'burn' of ranitidine recall: current insights and mitigation strategies.1 passage
• The Inflammatory Bowel Disease-Disability Index: validation of the Portuguese version according to the COSMIN checklist.1 passage
• The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.1 passage
• The Malnutrition Universal Screening Tool can predict malnutrition in patients with esophageal achalasia.1 passage
• The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia.1 passage
• The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.1 passage
• The age, bilirubin and albumin (ABA) index: a novel noninvasive index for predicting liver fibrosis in patients with chronic hepatitis C infection.1 passage
• The association between functional dyspepsia and depression: a meta-analysis of observational studies.1 passage
• The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis.1 passage
• The association between physical activity and the risk of symptomatic Barrett's oesophagus: a UK prospective cohort study.1 passage
• The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.1 passage
• The association of impaired lung function and nonalcoholic fatty liver disease: a systematic review.1 passage
• The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.1 passage
• The association of nonalcoholic steatohepatitis and hepatocellular carcinoma.1 passage
• The association of nonalcoholic steatohepatitis and obstructive sleep apnea.1 passage
• The association of plasma high-density lipoprotein cholesterol levels and cirrhosis development in obese patients with chronic hepatitis B: a cohort study.1 passage
• The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.1 passage
• The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission.1 passage
• The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations.1 passage
• The clinical usefulness of elastography in the evaluation of nonalcoholic fatty liver disease patients: A biopsy-controlled study.1 passage
• The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage.1 passage
• The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer.1 passage
• The correlations between hepatitis B virus infection and hepatocellular carcinoma with portal vein tumor thrombus or extrahepatic metastasis.1 passage
• The cost-effectiveness of daclatasvir-based regimens for the treatment of hepatitis C virus genotypes 1 and 4 in the UK.1 passage
• The cumulative false-positive rate in colorectal cancer screening: a Markov analysis.1 passage
• The defining of the reference range of liver stiffness and fat attenuation parameter for healthy Chinese children.1 passage
• The degree of mucosal damage to the small intestine and serum immunoglobulin G4 levels correlate with celiac disease.1 passage
• The diagnostic accuracy of ascitic calprotectin for the early diagnosis of spontaneous bacterial peritonitis: systematic review and meta-analysis.1 passage
• The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn's disease.1 passage
• The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis.1 passage
• The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.1 passage
• The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study.1 passage
• The diagnostic yield of preoperative staging computed tomography of the thorax in colorectal cancer patients without hepatic metastases.1 passage
• The dietary practices and beliefs of people living with inactive ulcerative colitis.1 passage
• The dietary practices and beliefs of people living with older-onset inflammatory bowel disease.1 passage
• The difference in endoscopic yield in patients with either iron-deficiency anemia or anemia with normal ferritin.1 passage
• The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: an Australian study.1 passage
• The effect of arthropathies on illness perceptions, coping strategies, outcomes, and their changes over time in patients with inflammatory bowel disease: a 12-month follow-up study.1 passage
• The effect of direct antiviral treatment on the depression, anxiety, fatigue and quality-of-life in chronic hepatitis C patients.1 passage
• The effect of intraoperative and 6-h postoperative intravenous administration of low-dose prostacyclin on the endothelium, hemostasis, and hemodynamics in patients undergoing a pancreaticoduodenoctemy: a randomized-controlled pilot study.1 passage
• The effect of malnutrition on the infectious outcomes of hospitalized patients with cirrhosis: analysis of the 2011-2017 hospital data.1 passage
• The effect of surgical fecal stream diversion of the healthy colon on the colonic microbiota.1 passage
• The effects of diabetes mellitus on clinical outcomes of hospitalized patients with acute diverticulitis.1 passage
• The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review.1 passage
• The efficacy and efficiency of stent-assisted percutaneous endoscopic necrosectomy for infected pancreatic necrosis: a pilot clinical study using historical controls.1 passage
• The efficacy and safety of endoscopic ultrasound-guided ablation of pancreatic cysts with alcohol and paclitaxel: a systematic review.1 passage
• The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective β-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis.1 passage
• The elderly harbor greater proportions of advanced histology in subcentimeter adenomas: implications for screening colonoscopy approaches.1 passage
• The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.1 passage
• The first episode of spontaneous bacterial peritonitis is a threat event in children with end-stage liver disease.1 passage
• The gastrointestinal endoscopy satisfaction questionnaire captures patient satisfaction as a key quality indicator of gastrointestinal endoscopy.1 passage
• The impact of acute kidney injury on mortality and clinical outcomes in patients with alcoholic cirrhosis in the USA.1 passage
• The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.1 passage
• The impact of primary biliary cholangitis on non-alcoholic fatty liver disease.1 passage
• The impact of submucosal fatty tissue during colon endoscopic submucosal dissection in a western center.1 passage
• The impact of undiagnosed primary biliary cholangitis.1 passage
• The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study.1 passage
• The incidence of gastrointestinal pathology and subsequent anemia in young men presenting with iron deficiency without anemia.1 passage
• The indicative role of markers for liver injury on the severity and prognosis of coronavirus disease 2019 patients.1 passage
• The inflammatory microenvironment in screen-detected premaligant adenomatous polyps: early results from the integrated technologies for improved polyp surveillance (INCISE) project.1 passage
• The interaction between current smoking and hemoglobin on the risk of advanced fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease.1 passage
• The interplay between gastrointestinal and cardiovascular diseases: a narrative review focusing on the clinical perspective.1 passage
• The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities.1 passage
• The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.1 passage
• The microbiology of necrotizing pancreatitis and its impact on in-hospital and 1-year all-cause mortality.1 passage
• The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD.1 passage
• The natural history of Crohn's disease in children: a review of population-based studies.1 passage
• The number of patients with chronic hepatitis C in times of new therapy options: a retrospective observational study on German health insurance funds data.1 passage
• The obestatin/ghrelin ratio and ghrelin genetics in adult celiac patients before and after a gluten-free diet, in irritable bowel syndrome patients and healthy individuals.1 passage
• The operation training for magnetically controlled capsule endoscopy.1 passage
• The operative risk and natural history after the diagnosis of ileal penetrating Crohn's disease.1 passage
• The outcome of transanal endoscopic microsurgery in obese patients.1 passage
• The overlap of gastroesophageal reflux disease and functional constipation in children: the efficacy of constipation treatment.1 passage
• The performance of M and XL probes of FibroScan for the diagnosis of steatosis and fibrosis on a Brazilian nonalcoholic fatty liver disease cohort.1 passage
• The possible relationship between Campylobacter spp./Arcobacter spp. and patients with ulcerative colitis.1 passage
• The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.1 passage
• The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers.1 passage
• The potential value of miRNA-223 as a diagnostic biomarker for Egyptian colorectal patients.1 passage
• The presence of periampullary diverticulum increased the complications of endoscopic retrograde cholangiopancreatography.1 passage
• The prevalence and co-occurrence of hematological complications at the time of diagnosis of chronic hepatitis C in Poland: a cross-sectional study.1 passage
• The prevalence and impact of thrombocytopenia, anaemia and leucopenia on sustained virological response in patients receiving hepatitis C therapy: evidence from a large 'real world' cohort.1 passage
• The prevalence and sociodemographic determinants of uninvestigated dyspepsia in the Czech Republic: a multicentre prospective study accomplished 10 years after the first study from the same geographical areas.1 passage
• The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.1 passage
• The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.1 passage
• The prevalence of sessile serrated lesion in the colorectum and its relationship to synchronous colorectal advanced neoplasia: a systemic review and meta-analysis.1 passage
• The prevalence of symptomatic uncomplicated diverticular disease could be lower than expected: a single-center colonoscopy-based cohort study.1 passage
• The prevalence of viral agents in esophageal adenocarcinoma and Barrett's esophagus: a systematic review.1 passage
• The prevention and management of Crohn's disease postoperative recurrence: results from the Y-ECCO/ClinCom 2019 Survey.1 passage
• The prognostic impact of different stages of acute kidney injury in patients with decompensated cirrhosis: a prospective cohort study.1 passage
• The prognostic value of P-wave dispersion and left atrial functions assessed with three-dimensional echocardiography in patients with cirrhosis.1 passage
• The prognostic value of the neutrophil-to-lymphocyte ratio in critically ill cirrhotic patients.1 passage
• The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.1 passage
• The relationship between liver histology and noninvasive markers in primary biliary cirrhosis.1 passage
• The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis.1 passage
• The relationship between urinary genistein levels and serum alanine aminotransferase levels in adults in the USA: National Health and Nutrition Examination Survey 1999-2010.1 passage
• The risk of residual or recurring adenoma after piecemeal endoscopic mucosal resection of large non-pedunculated colorectal polyps is predictable.1 passage
• The role of Fibroscan in predicting the presence of varices in patients with cirrhosis.1 passage
• The role of ascitic fluid viscosity in differentiating the nature of ascites and in the prediction of renal impairment and duration of ICU stay.1 passage
• The role of capsule endoscopy in the diagnosis and treatment of obscure gastrointestinal bleeding in older individuals.1 passage
• The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.1 passage
• The role of coexisting cardiovascular disease on disease severity in patients with inflammatory bowel disease.1 passage
• The role of dietary supplements in inflammatory bowel disease: a systematic review.1 passage
• The role of endoscopic intervention in the management of inflammatory pancreatic fluid collections.1 passage
• The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis.1 passage
• The role of intrasphincteric botulinum toxin injection in the management of functional biliary pain: a systematic review and meta-analysis.1 passage
• The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus.1 passage
• The role of nursing care in the type 2 diabetes treatment associated with chronic liver diseases.1 passage
• The role of plasma exchange in hypertriglyceridemia-induced acute pancreatitis.1 passage
• The role of small bowel capsule endoscopy and ileocolonoscopy in patients with nonspecific but suggestive symptoms of Crohn's disease.1 passage
• The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis.1 passage
• The role of upper gastrointestinal endoscopy in the era of modern antiretroviral therapy.1 passage
• The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data.1 passage
• The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B.1 passage
• The semirecumbent position for high-resolution esophageal manometry. Results of a feasibility study.1 passage
• The significance of the small adenoma: a longitudinal study of surveillance colonoscopy in an Australian population.1 passage
• The slow-pull capillary technique increases the quality of endoscopic ultrasound fine needle biopsy samples in solid pancreatic lesions.1 passage
• The socioeconomic profile of a Barrett's oesophagus cohort assessed by the 2010 Index of Multiple Deprivation.1 passage
• The use of β-blockers is associated with a lower risk of developing hepatocellular carcinoma in patients with cirrhosis.1 passage
• The utility and yield of endoscopic ultrasonography for suspected choledocholithiasis in common gastroenterology practice.1 passage
• The utility of two-dimensional real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis C virus infection.1 passage
• The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.1 passage
• The yield of colonic biopsy in the evaluation of chronic unexplained diarrhea.1 passage
• The yield of endoscopic investigation for unintentional weight loss.1 passage
• Therapeutic advances for primary biliary cholangitis: the old and the new.1 passage
• Therapeutic drug monitoring in Crohn's disease patients treated with anti-TNF: a comparison of two techniques.1 passage
• Therapeutic drug monitoring of infliximab in inflammatory bowel disease patients in a teaching hospital setting: results of a prospective cohort study.1 passage
• Therapeutic outcomes of endoscopic submucosal dissection for early gastric cancer: single-center study.1 passage
• Thirty-day readmission rates, reasons, and costs for gastrointestinal angiodysplasia-related bleeding in the USA.1 passage
• Thromboelastography versus standard coagulation testing in the assessment and reversal of coagulopathy among cirrhotics: a systematic review and meta-analysis.1 passage
• Thromboembolism as an important complication of inflammatory bowel disease.1 passage
• Thrombotic risk factors in Chinese nonmalignant and noncirrhotic patients with portal vein thrombosis: an observational study with a systematic review of the literature.1 passage
• Time to antibody detection and associated factors for presence of anti-drug antibodies in pediatric inflammatory bowel disease patients treated with anti-TNF therapy.1 passage
• Time trends in the epidemiology and outcome of perianal fistulizing Crohn's disease in a population-based cohort.1 passage
• Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosis.1 passage
• Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.1 passage
• Transient elastography can stratify patients with Child-Pugh A cirrhosis according to risk of early decompensation.1 passage
• Transient elastography evaluation of hepatic and spleen stiffness in patients with hepatosplenic schistosomiasis.1 passage
• Transient elastography for assessing severe hepatic fibrosis in diabetic patients with nonalcoholic fatty liver disease: definitions matter.1 passage
• Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.1 passage
• Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men.1 passage
• Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.1 passage
• Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals.1 passage
• Transjugular intrahepatic portosystemic shunt in refractory ascites: clinical impact of left ventricular diastolic dysfunction.1 passage
• Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.1 passage
• Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study.1 passage
• Transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with hepatocellular carcinoma meeting the Milan criteria.1 passage
• Transjugular intrahepatic portosystemic shunt with transhepatic portal vein puncture guided by ultrasound: a technical alternative.1 passage
• Transjugular liver biopsy and hepatic venous pressure gradient measurement in patients with and without liver cirrhosis.1 passage
• Transparent cap-assisted endoscopic sclerotherapy in esophageal varices: a randomized-controlled trial.1 passage
• Treatment in disproportionately minority hospitals is associated with an increased mortality in end-stage liver disease.1 passage
• Treatment of Hermansky-Pudlak syndrome Associated granulomatous colitis with anti-TNF agents: case series and review of literature.1 passage
• Treatment of hepatitis B virus infection in chronic infection with HBeAg-positive adult patients (immunotolerant patients): a systematic review.1 passage
• Treatment of hepatitis C with direct-acting antivirals significantly reduces liver-related hospitalizations in patients with cirrhosis.1 passage
• Treatment of hepatocellular carcinoma using transarterial chemoembolization: a real-life, single-centre study from Southern Brazil.1 passage
• Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.1 passage
• Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers.1 passage
• Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer.1 passage
• Trends in survival based on treatment modality for esophageal cancer: a population-based study.1 passage
• Trimodal imaging endoscopy reduces the risk of synchronous gastric neoplasia.1 passage
• Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients.1 passage
• Tumor size is not a criterion for resection during the management of giant hemangioma of the liver.1 passage
• Tumor-associated antigens and their antibodies in the screening, diagnosis, and monitoring of esophageal cancers.1 passage
• Two-dimensional shear-wave elastography: a new method comparable to acoustic radiation force impulse imaging?1 passage
• Ulcerative enteritis. How the extension of ulcerative colitis to small bowel may jeopardize postcolectomy course: a case report and literature review.1 passage
• Ultrasonographic assessment of right heart intracardiac mass in patients with hepatitis B virus infection.1 passage
• United European Gastroenterology Week scientific abstracts and their progression to full publication.1 passage
• Update on the role of chromoendoscopy in colonoscopic surveillance of patients with Lynch syndrome.1 passage
• Upper gastrointestinal hemorrhage is associated with poor outcomes among patients with acute cholangitis: a nationwide analysis.1 passage
• Upregulation of microRNA-219-5p relieves ulcerative colitis through balancing the differentiation of Treg/Th17 cells.1 passage
• Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries.1 passage
• Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.1 passage
• Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.1 passage
• Usefulness of mean corpuscular volume as a surrogate marker for monitoring thiopurine treatment in inflammatory bowel disease.1 passage
• Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease.1 passage
• Usefulness of radiographic targeting on the evaluation of the location of a patency capsule using abdominal ultrasonography.1 passage
• Usefulness of serial FIB-4 score measurement for predicting the risk of hepatocarcinogenesis after hepatitis C virus eradication.1 passage
• Usefulness of the Glasgow-Blatchford score to predict 1-week mortality in patients with esophageal variceal bleeding.1 passage
• Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures.1 passage
• Ustekinumab concentrations shortly after escalation to monthly dosing may identify endoscopic remission in refractory Crohn's disease.1 passage
• Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's disease.1 passage
• Utility of post-liver transplantation MELD and delta MELD in predicting early and late mortality.1 passage
• Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry.1 passage
• Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study.1 passage
• Validation of models in patients with hepatocellular carcinoma: comparison of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging system in a Chinese cohort.1 passage
• Validation of the English version of the difficulty of life scale for patients with ulcerative colitis.1 passage
• Validation of the Portuguese version of a questionnaire to measure Quality of Care Through the Eyes of Patients with Inflammatory Bowel Disease (QUOTE-IBD).1 passage
• Value of Adjusted Blood Requirement Index in determining failure to control bleed in patients with variceal bleeding.1 passage
• Variceal bleeding has increased mortality compared to nonvariceal bleeding only in males.1 passage
• Vedolizumab-induced acute interstitial lung injury in a 39-year-old male with ulcerative colitis.1 passage
• Very low rate of residual neoplasia after non-curative endoscopic submucosal dissection: a western single-center experience.1 passage
• Viral hepatitis screening in transgender patients undergoing gender identity hormonal therapy.1 passage
• Vitamin B12 deficiency in inflammatory bowel disease: a prospective observational pilot study.1 passage
• Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.1 passage
• Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?1 passage
• Vitamin D-related immunomodulation in patients with liver cirrhosis.1 passage
• Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.1 passage
• Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.1 passage
• Western long-term accuracy of serum pepsinogen-based gastric cancer screening.1 passage
• What recovery position should patients adopt after percutaneous liver biopsy?1 passage
• What to eat and drink in the festive season: a pan-European, observational, cross-sectional study.1 passage
• Whipple's disease: diagnosis and predictive factors of relapse.1 passage
• Who are the patients with Crohn's disease unsuitable to receive an anti-TNFα therapy? Results from a survey of Italian physicians and literature review.1 passage
• Whole-liver diffusion-weighted MRI histogram analysis: effect of the presence of colorectal hepatic metastases on the remaining liver parenchyma.1 passage
• Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers.1 passage
• Wire-guided biliary cannulation: a comprehensive approach to a set of techniques.1 passage
• Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study.1 passage
• Young age and tobacco use are predictors of lower medication adherence in inflammatory bowel disease.1 passage
• microRNA in inflammatory bowel disease at a glance.1 passage
• β-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial.1 passage
• β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case-control study.1 passage